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Subclinical bacteriuria is reported in up to 25-30% of cats, particularly those with predisposing 
factors such as chronic kidney disease, diabetes mellitus or hyperthyroidism. The diagnostic 
approach and treatment guidelines for feline subclinical bacteriuria are not always clear which 
can lead to the overuse of antimicrobial agents and thus the selection of multidrug-resistant 
bacteria.   
This study reported the prevalence of subclinical bacteriuria in a population of 56 cats referred 
to Langford Vets Small Animal Hospital and described all cases of positive urine cultures as a 
series. Demographic data was collected for each cat and medical records were screened to 
identify any at-risk populations for subclinical bacteriuria or urinary tract infections. Routine 
urinalyses, including sediment examination and urine culture were performed on voided urine 
samples and cystocentesis samples. Proteomic techniques were utilised to identify a 
biomarker of infection or inflammation of the lower urinary tract. Finally, a method 
comparison study was conducted to investigate the effect of non-absorbent hydrophobic sand 
litter on the urine protein-to-creatinine ratio followed by a study comparing the effect of urine 
collection technique on common urinalysis parameters.  
The prevalence of subclinical bacteriuria in this population was 4%. All affected cats were 
female and over 6 years old. Myeloperoxidase was identified in all cases of subclinical 
bacteriuria and urinary tract infection and so further studies exploring the utility of this 
enzyme as a biomarker seem justified. Non-absorbent hydrophobic sand litter did not interfere 
with urine protein-to-creatinine ratio measurements and agreement between the ratio 
determined from voided urine and cystocentesis samples appeared excellent for urine with an 
inactive sediment and urine protein-to-creatinine ratio <0.5. Bacterial growth was significantly 
more likely in voided samples compared to cystocentesis samples, p<0.0005, although this 
difference was not significant when accepted quantitative cut-off values for bacterial growth in 
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Chapter 1  INTRODUCTION 
1.1 BACKGROUND 
Clinical signs of lower urinary tract disease occur frequently in cats, yet urinary tract infections 
(UTI) confirmed by bacterial culture represent only a small percentage of cases presenting with 
such signs. In contrast, up to 30% of urine cultures from cats without any current or historical 
signs of lower urinary tract disease may be positive for bacterial growth (Litster et al., 2009). 
These apparent contradictory findings can make antimicrobial prescribing challenging for 
veterinary practitioners. Clear evidence-based guidelines exist in human medicine outlining 
when antimicrobial therapy is warranted in cases of positive urine cultures (Nicolle et al., 
2005). Although guidelines do exist in veterinary medicine, the evidence base is somewhat 
lacking and many recommendations have been extrapolated from human data (Weese et al., 
2019).  
Antimicrobial therapy is not a benign treatment and their unnecessary use has been associated 
with selection of multidrug-resistant bacteria, dysbiosis of intestinal flora leading to an 
increased risk of Clostridium difficile infections and a range of gastrointestinal side effects 
(Trautner, 2012). The close physical relationship between companion animals and their owners 
may play a role in the dissemination of antimicrobial resistance, impacting both human and 
animal health (Harrison et al., 2014). In this era of One Health, antimicrobial stewardship is 
therefore of utmost importance in both human and veterinary medicine. 
Urinary tract infections are a leading cause of antimicrobial prescription in human and 
veterinary medicine (Cordoba et al., 2015). The current gold standard test for the diagnosis of 
UTI, urine culture, can take 48 hours or longer to obtain results (Bartges, 2004). Urine culture 
is not a perfect test and a need therefore exists for improved ways in which to diagnose UTI 
and subclinical bacteriuria to enable prudent use of antimicrobials in the future. 
1.2 AIMS AND OBJECTIVES 
This research project aimed to identify the prevalence of subclinical bacteriuria and UTI in a 
population of cats referred to the Small Animal Hospital of Langford Vets as well as identify 
any results of urinalyses that could discriminate between subclinical and clinical infections. 
Diagnostic tests were applied to voided urine samples and cystocentesis samples to determine 
whether results were valid for both methods of collection.  
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As a preliminary investigation, proteomic techniques were utilised to identify potential urinary 
biomarkers for feline subclinical bacteriuria and UTIs. Again, proteomic techniques were 
applied to voided urine samples and cystocentesis samples to compare differences in protein 
expression between methods of collection. Any potential biomarkers identified through 
proteomic analysis could be exploited for future research with a long-term aim of the 
development of a patient-side test for the diagnosis of subclinical bacteriuria or UTI.  
During data collection it became clear the prevalence of subclinical bacteriuria and UTI within 
our population was insufficient to provide adequate power for statistical analyses to be 
performed and meaningful conclusions be drawn. Other research questions had been 
generated from the preliminary work of this project and the decision was made to explore 
these areas further alongside describing any cases of subclinical bacteriuria and UTI and 
highlighting differences between methods of urine sampling.   
The four main themes that were investigated as part of this project and their intended 
outcomes were: 
1) To investigate the diagnostic approach to feline subclinical bacteriuria and UTI: 
i) Determine the prevalence of subclinical bacteriuria and UTI within a referral 
population.  
ii) Describe all cases of subclinical bacteriuria and UTI highlighting any differences in 
urinalyses results between voided samples and cystocentesis samples. 
iii) Review the medical records of cases of subclinical bacteriuria to identify any at-risk 
populations. 
 
2) Proteomic analysis of urine sediments and cultured bacteria: 
i) Identify a potential biomarker(s) that could be used to discriminate between 
subclinical bacteriuria and UTI in cats.  
ii) To determine whether any potential biomarker identified was present in voided 
samples and cystocentesis samples.  
iii) To determine whether proteomic techniques could identify the causative pathogen of 
any case of subclinical bacteriuria or UTI. 
 
3) To investigate the effect of non-absorbent hydrophobic sand litter on urine protein-to-
creatinine ratio (UPC) measurements: 
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i) To evaluate whether a commonly used non-absorbent litter accounts for any 
preanalytical variability when determining the UPC in cats. 
4) To investigate the effect of urine sample collection technique on common urinalysis 
parameters, particularly the UPC: 
i) To determine whether results of urinalyses, including sediment examination, and urine 
culture different significantly between voided samples and cystocentesis samples.  
ii) To assess whether the UPC determined from voided urine samples collecting using 
non-absorbent hydrophobic sand litter differed significantly from the UPC determined 
from cystocentesis samples. 
iii) To measure agreement between the UPC of voided urine samples and cystocentesis 
samples and assess whether this differed according to urine sediment status.  
1.3 POTENTIAL BENEFITS OF THIS WORK 
At present there is currently a lack of good evidence regarding the treatment of subclinical 
bacteriuria in cats. Little is also known about the prevalence of subclinical bacteriuria in the 
United Kingdom. In human medicine clear guidelines exist outlining when antimicrobial 
therapy is warranted in cases of asymptomatic bacteriuria yet up to one-third of patients with 
asymptomatic bacteriuria are prescribed antimicrobials unnecessarily (Kjolvmark et al., 2016). 
A need therefore exists for a test to be able to differentiate between UTI and asymptomatic 
bacteriuria/subclinical bacteriuria in order to reduce the overuse of antimicrobials. 
In veterinary medicine, cystocentesis is considered the gold standard means of urine collection 
when bacterial culture is required. This is an invasive procedure whereby urine is collected 
percutaneously from the bladder using a sterile needle and syringe. Sedation may be required 
to facilitate urine collection by cystocentesis which can lead to increased client costs, an 
increased duration of visit to the veterinary practice and increased patient stress, all of which 
could be mitigated if voided urine samples collected in the home environment were shown to 
be of diagnostic value.  
Urine culture and susceptibility testing can take at least 48 hours to obtain results. Empiric 
antimicrobial therapy is often initiated in cases of suspected UTI and studies have shown that 
even upon receipt of negative culture results, veterinary surgeons do not always advise clients 
to discontinue antimicrobial therapy (Sorensen et al., 2018). The use of fluoroquinolone and 
cephalosporin antimicrobials has been shown to select for methicillin-resistant Staphylococcus 
aureus and extended-spectrum β-lactamase producing-Escherichia coli (E. coli) in human 
medicine and so their overuse is of concern (Guardabassi and Prescott, 2015).  Proteomic 
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techniques have the potential to identify a biomarker which could seed the development of a 
rapid patient-side test; this in turn would improve antimicrobial prescribing in veterinary 
practice and reduce the development of antimicrobial resistance.  
The UPC is frequently determined in number of disease states including glomerulopathies, 
hypertension and chronic kidney disease (CKD) and it has both diagnostic and prognostic 
implications (Lees et al., 2005, Syme, 2009). Correlation exists between UPCs determined from 
voided samples and cystocentesis samples in dogs and cats, but it is not known whether the 
use of non-absorbent hydrophobic sand litter interferes with UPC measurement (Beatrice et 
al., 2010, Vilhena et al., 2015). Should it be proved that the use of a non-absorbent litter does 
not affect UPC measurement, urine samples intended for this purpose could also be collected 
in the home environment. This work has the potential to increase the frequency of which the 
UPC is determined in feline patients enabling disease processes to be picked up, and therefore 
treatment plans be instigated, earlier.  
1.4 THESIS OUTLINE 
This thesis begins with a review of the current literature concerning feline subclinical 
bacteriuria and UTI, urinary proteomics, the urinary microbiome and the UPC. This review 
concentrates on the aforementioned areas within feline medicine but where appropriate 
comparisons to other veterinary species and human medicine are made.  
Following on from this are chapters describing the methodology and results for each study 
within the project. Any conclusions drawn and any potential limitations of each study are 
outlined in the discussion chapter. The final chapter of this thesis discusses opportunities for 
future research that have arisen as part of this project.  
Full descriptions of proteins identified in each urine sample in Sections 4.2.2 and 4.2.3 are 
provided as supplementary information (S1-S14). Data are available at the University of Bristol 
data repository, data.bris, at http://doi.org/10.5523/bris.2k17yid6ng8hu24xboldyrkj2y 
(Maunder & Kennils, 2020). 
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Chapter 2  LITERATURE REVIEW 
2.1 URINARY TRACT INFECTIONS AND SUBCLINICAL BACTERIURIA 
2.1.1 Definitions 
Bacterial UTI refers to bacterial colonisation of the urinary tract in which bacterial adhesion 
and invasion of host cells, replication and survival incites an inflammatory response and clinical 
signs of lower urinary tract disease (Teichmann-Knorrn et al., 2018, Weese et al., 2019).  
Subclinical bacteriuria is defined as a positive bacterial urine culture in the absence of lower 
urinary tract clinical signs. The most recent guidelines by the International Society for 
Companion Animal Infectious Diseases (ISCAID) for the diagnosis and management of bacterial 
urinary tract infections in dogs and cats refined this definition to specify that urine samples 
should be ‘properly collected’ discouraging clinicians from using voided urine samples for 
bacterial culture (Weese et al., 2019). Subclinical bacteriuria has previously been referred to as: 
asymptomatic bacteriuria, occult urinary tract infections and covert urinary tract infections 
(Litster et al., 2009, Eggertsdottir et al., 2011). Asymptomatic bacteriuria is the term used to 
describe the same phenomenon in human patients and has been well studied (Nicolle et al., 
2005). 
2.1.2 Prevalence 
The prevalence of UTI in cats presenting with lower urinary tract signs has typically been 
reported as <3% (O'Neill et al., 2014, Dorsch et al., 2015), however other studies across Europe 
suggest the prevalence may be as high as 12% (Gerber et al., 2005, Saevik et al., 2011). The 
reported prevalence of subclinical bacteriuria in cats varies widely from 0.9-29% (Litster et al., 
2009, Eggertsdottir et al., 2011). More recent prospective studies report a more consistent 
prevalence of 6-13% (White et al., 2016, Moberg et al., 2019). 
Over a five-year period, Litster et al. (2009) identified 38 out of 132 (29%) urine samples 
obtained by cystocentesis from cats with no prior history of lower urinary tract clinical signs 
were positive on culture. The median age of cats with a positive culture in this study was 14 
years which was considerably higher than the median age of 4 years from the Eggertsdottir et 
al. (2011) study. Eggertsdottir et al. (2011) conducted a prospective study to identify the 
prevalence of subclinical bacteriuria in healthy cats. One hundred and eight urine samples 
were obtained by cystocentesis from cats deemed healthy based on owner history and the 
results of a physical examination, complete blood count and serum biochemistry profile. One 
Chapter 2 - Literature Review 
6 
 
urine sample was positive on culture with >105 cfu/ml of Enterococcus species and 
Staphylococcus species documented.  
The large discrepancy in reported prevalence data is likely multi-factorial. Increased age has 
been identified as a risk factor for UTI and subclinical bacteriuria in cats (Lekcharoensuk et al., 
2001, White et al., 2016). The inclusion criteria of the Eggertsdottir et al. (2011) study was 
stricter and prevented the inclusion of cats with CKD, diabetes mellitus (DM) and 
hyperthyroidism in which subclinical bacteriuria is more prevalent (Mayer-Roenne et al., 2007, 
Bailiff et al., 2008, White et al., 2016). Geographically these studies were conducted in 
Australia and Norway respectively which also may have contributed to the difference in 
prevalence reported.  
2.1.3 Risk Factors 
Sporadic UTI occur less commonly in cats than dogs (Weese et al., 2019). Risk factors 
predisposing to UTI or subclinical bacteriuria are reported in up to 87% of cats with positive 
urine cultures (Dorsch et al., 2019).  
Disease states such as CKD, DM and hyperthyroidism have been associated with an increased 
risk of both UTI and subclinical bacteriuria (Mayer-Roenne et al., 2007, Puchot et al., 2017). 
Chronic kidney disease, DM and uncontrolled hyperthyroidism can lead to the production of 
poorly concentrated urine which may increase the risk of bacterial colonisation of the urinary 
tract (Sparkes et al., 2016, Sparkes et al., 2015, Carney et al., 2016). The association between 
urine specific gravity (USG) and UTI has been evaluated in many studies with conflicting 
conclusions (Martinez-Ruzafa et al., 2012, Bailiff et al., 2006, Bailiff et al., 2008, Lund et al., 
2013, Mayer-Roenne et al., 2007). 
The largest of which is the retrospective study by Bailiff et al. (2008) in which the medical 
records and urinalysis results of 614 cats with either CKD, DM, uncontrolled hyperthyroidism 
or lower urinary tract disease were evaluated in order to identify risk factors for positive urine 
cultures. Positive urine cultures were identified in 17%, 13%, 22% and 5% of each group 
respectively. The authors found no association between a reduced urine concentrating ability 
and a positive urine culture in any disease group. These findings were in agreement with an 
earlier study by the same author in which an association between USG and UTI was not 
established in cats with DM (Bailiff et al., 2006). This study is limited by its retrospective nature 
in that urine culture was only performed as directed by the attending clinician, prevalence 
rates of UTI in these patient groups may therefore have been over- or underestimated. By 
using control cats from the same disease group but with a negative culture, it is possible the 
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study control population also had reduced urine concentrating ability making associations 
between USG and UTI more difficult to ascertain.  
In a later retrospective study of 155 cats with UTI and 186 control cats, Martinez-Ruzafa et al. 
(2012) identified that a reduced urine concentrating ability was significantly associated with 
UTI using a multivariable logistic regression model, p=0.0055. This study partly agreed with 
Mayer-Roenne et al. (2007) who identified a significant association between a USG <1.020 and 
a positive urine culture in cats with DM but no association was identified between USG and UTI 
in cats with CKD or hyperthyroidism.  
Finally, Lund et al. (2013) evaluated the urinalyses of 111 cats that presented to a first opinion 
practice with clinical signs compatible with lower urinary tract disease. Cats were classified as 
having either: idiopathic cystitis, urethral plugs, bacterial cystitis or urolithiasis. Although USG 
was excluded from the statistical modelling of this study due to many of the cats receiving 
intravenous fluid therapy, the authors commented that no significant difference in USG was 
identified between the different causes of lower urinary tract disease. 
The contrasting results from these studies suggest that mechanisms beyond a reduced urine 
concentrating ability such as impaired host defences may contribute to the increased 
prevalence of UTI reported in these patient groups. 
Surgical interventions such as perineal urethrostomy or renal decompressive surgeries are 
reported risk factors for both UTI and subclinical bacteriuria (Bass et al., 2005, Kopecny et al., 
2019). Griffin and Gregory (1992) proposed that underlying compromised host defences 
contributed more to the increased prevalence of UTI seen in cats with perineal urethrostomies 
rather than the anatomic changes caused by the surgery. In their study, increased prevalence 
of recurrent UTI and subclinical bacteriuria was documented in cats undergoing perineal 
urethrostomy due persistent urethral obstruction compared to healthy cats undergoing the 
same surgery.  
Urological implants such as ureteral stents or subcutaneous ureteral bypass (SUB) devices are 
indicated in cases of ureteral obstruction that are non-responsive to medical management 
(Berent et al., 2018). The most common cause of ureteral obstruction in cats is ureterolithiasis, 
which itself appears to predispose to UTI (Wormser et al., 2016). In a retrospective study of 43 
cats having either a ureteral stent or SUB device placed surgically, Kopecny et al. (2019) 
reported post-operative positive urine cultures in 25% of cats. This study also reported that 
cats that received post-operative antimicrobials were significantly less likely to develop a 
positive urine culture. Uropathogens such as E. coli and Enterococcus spp. are able to form 
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biofilms on urological implants, and this has been a proposed mechanism for the increased risk 
of positive urine cultures in this population (Arias and Murray, 2012, Flores-Mireles et al., 2015, 
Kopecny et al., 2019). 
Long-term glucocorticoid treatment and other immunosuppressive agents have been reported 
as a risk factor for UTI in dogs (Torres et al., 2005), but no evidence exists supporting this 
increased risk in cats (Lockwood et al., 2018). 
2.1.4 Pathogens 
Common pathogens isolated from cats with UTI are also frequently isolated in cases of 
subclinical bacteriuria (Puchot et al., 2017, Teichmann-Knorrn et al., 2018). E. coli is 
consistently reported as the most frequent pathogen isolated from the urinary tract of cats, 
followed by Staphylococcus spp. and Enterococcus spp. (Lund et al., 2015, Marques et al., 
2018). 
In a retrospective study evaluating antimicrobial resistance patterns of feline uropathogens in 
Germany, Teichmann-Knorrn et al. (2018) reported that Enterococcus spp. were significantly 
more likely to be isolated from cats with subclinical bacteriuria compared to cats with UTI. 
Enterococcal infections are also frequently reported in cats with urological implants although 
whether these infections are more likely to produce clinical UTIs or subclinical bacteriuria is 
currently unclear (Berent et al., 2018, Kopecny et al., 2019). 
Most cases of UTI and subclinical bacteriuria involve only one pathogen, although 
polymicrobial infections have been reported in up to 25% of cases (Byron, 2018). Where 
polymicrobial infections involve pathogens that may typically be seen as low-pathogenic such 
as Enterococcus spp., KuKanich and Lubbers (2015) suggest targeting antimicrobial therapy 
towards the more pathogenic organisms present may be successful in eliminating all organisms.  
2.1.5 Diagnosis 
2.1.5.1 Clinical signs 
Clinical signs of lower urinary tract disease may include haematuria, dysuria, stranguria, 
periuria or pollakiuria although no combination of lower urinary tract disease clinical signs are 
pathognomonic for UTI (Gunn-Moore, 2003). The presence of lower urinary tract clinical signs 
cannot be used to exclude a diagnosis of subclinical bacteriuria as cases of idiopathic cystitis 
with concurrent subclinical bacteriuria have been reported (Lund and Eggertsdottir, 2019). 
  




Fundamentally, quantitative bacterial culture of urine is required for diagnosis of UTI or 
subclinical bacteriuria although the indications for urine culture in cats without clinical signs of 
lower urinary tract disease are few (Weese et al., 2019). Results of urinalyses, including 
sediment examination, may increase suspicion of UTI or subclinical bacteriuria (Piech and 
Wycislo, 2018). 
2.1.5.2.a Colour and Turbidity 
Pigmenturia is reported to be a leading cause for cat owners to seek veterinary advice and in 
one recent study of 77 cats evaluated for lower urinary tract disease, 55% of cats presented 
with haematuria. Of 5 cats diagnosed with a UTI in the study, 4 presented with gross 
haematuria (Reppas and Foster, 2016a, Gerber et al., 2005). Blue-green discolouration of urine 
has rarely been reported in association with Pseudomonas aeruginosa UTI (Reppas and Foster, 
2016a). 
In a study investigating the association between lower urinary tract clinical signs and UTI in 424 
dogs, gross haematuria was found to be a significant predictor of UTI. Of 198 dogs presenting 
with gross haematuria, 54% were diagnosed with a UTI (Sorensen et al., 2019). A similar study 
in cats has yet to be conducted, although the % of cats presenting with haematuria diagnosed 
with UTI would likely be much lower due to the increased prevalence of feline specific disease 
processes that can cause haematuria, such as idiopathic cystitis (Sparkes, 2018). 
2.1.5.2.b Urine Specific Gravity 
Whether a reduced USG predisposes to UTI or subclinical bacteriuria is discussed in section 
2.1.3. In a retrospective study of 500 cats, USG did not differ significantly between cats with 
subclinical bacteriuria and control cats (Puchot et al., 2017). 
2.1.5.2.c pH 
Urinary tract infections caused by urease-producing bacteria such as Staphylococcus aureus, 
Staphylococcus felis, Proteus spp., or Klebsiella spp. can lead to alkalinuria (Reppas and Foster, 
2016a). In the study by Litster et al. (2009), in which 38 out of 132 urine samples obtained by 
cystocentesis from cats without clinical signs of lower urinary tract disease were positive on 
urine culture, a significantly higher urine pH was identified in culture positive samples, 
p=0.0002. The association between an increased urinary pH and subclinical bacteriuria 
however was not found in a more recent retrospective study (Puchot et al., 2017). This 
disagreement may in part be due to the pathogens identified in each study, with a higher % of 
urease-producing bacteria cultured in the study by Litster et al. (2009). 
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2.1.5.2.d Dipstick Evaluation 
Dipstick analysis provides a semiquantitative measure of the chemical properties of urine. 
Common parameters measured by standard dipsticks include specific gravity, pH, leukocytes, 
nitrites, protein, glucose, ketones, urobilinogen, bilirubin and blood/haemoglobin. Urine 
specific gravity, leukocytes, nitrite and urobilinogen are reported to be unreliable when 
analysing feline urine (Piech and Wycislo, 2018, Reppas and Foster, 2016a). Dipstick analysis 
can be performed manually, by visually comparing the colours of the reagent pad to a result 
chart, or by using an automatic dipstick reader. In environments where multiple personnel 
perform urinalysis, automated readers have been shown to provide superior precision 
compared to manual reading of results for glucose, ketones, bilirubin, blood, protein and pH. 
The most frequent error observed when performing manual readings is failing to observe 
waiting times  prior to reading a result which is overcome by the use of an automated reader 
(Ferreira et al., 2018). 
In one study evaluating the dipstick leukocyte pad for the detection of pyuria in feline urine, 
Holan et al. (1997) compared the dipstick result to that obtained from manual microscopy for 
213 urine samples. The authors reported a sensitivity and specificity of 77% and 34% 
respectively and a positive and negative predictive value of 14% and 91% respectively. The test 
performance reported is poor when compared to human medicine, in which sensitivities and 
specificities of 69-96% and 69-98% are reported. The authors concluded that the leukocyte pad 
of standard urine dipsticks is not reliable for the analysis of feline urine and that sediment 
examination should be utilised to confirm the presence of pyuria.  
An increased prevalence of UTI and asymptomatic or subclinical bacteriuria has been reported 
in diabetic human, canine and feline populations although the specific mechanisms for 
increased risk of infection have yet to be properly defined (McGuire et al., 2002, Bailiff et al., 
2006, Flores-Mireles et al., 2015). The presence of glucosuria has been proposed as one 
mechanism of increased susceptibility to UTI by permitting increased bacterial growth 
although no direct association between glucosuria and UTI risk has been identified in human 
diabetic patients or diabetic dogs (Bailiff et al., 2006, Chen et al., 2009). Other proposed 
mechanisms of increased susceptibility to UTI in diabetic populations include: an altered host 
immune response to infectious agents, diabetic associated neuropathies altering micturition 
patterns and enhanced binding between uropathogens and uroepithelial cells (Bailiff et al., 
2006, Chen et al., 2009). 
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One retrospective prevalence study of UTIs in diabetic cats did identify a significant association 
between glucosuria and risk of UTI development (Mayer-Roenne et al., 2007). This is however 
in disagreement with a larger retrospective study evaluating urinalyses of diabetic cats with 
and without UTI in which no significant association between glucosuria and UTI was 
established (Bailiff et al., 2006). Zeugswetter et al. (2019) recently demonstrated that very low 
concentrations of glucose were present in a population of 132 healthy cats. These 
concentrations were below the limit of detection for standard urinary dipsticks. Enrolled cats 
were considered to be euglycaemic based on blood glucose testing although a delay between 
blood sampling and glucose testing of up to 5 hours occurred in some cases. This delay could 
have allowed the inclusion of cats with a blood glucose concentration above the renal 
threshold of 14mmol/L as delayed sample processing without the addition of an anti-glycoltic 
agent can cause an artefactual reduction in blood glucose measurements. Further prospective 
studies are needed to enhance the understanding between glucosuria and UTI pathogenesis 
although the increased prevalence of UTI in diabetic populations is likely multi-factorial. 
Haematuria is a non-specific finding in UTIs and may also been seen in other disease processes 
such as neoplasia, coagulopathies, inflammatory processes and idiopathic disorders. Iatrogenic 
haemorrhage can be caused when obtaining urine samples via manual compression, 
cystocentesis or catheterisation (Manfredi et al., 2018). The sensitivity of the blood pad is 
reported to be between 5-50 intact RBC/µL of urine whereas gross haematuria occurs with 
approximately 2500 RBC/µL. The strongest reaction of the blood pad (+++) occurs with >200 
RBC/µL (Sink and Weinstein, 2012, Reppas and Foster, 2016a). A positive reaction for blood on 
dipstick evaluation should be confirmed with sediment examination (Piech and Wycislo, 2018). 
2.1.5.2.e Sediment Examination  
Urine sediment examination should be performed in a standardised manor and a minimum 
starting volume of 5mL is suggested. Relative centrifugation forces should not exceed 400rcf 
(where rcf = 1.12 x Radius x (rpm/1000)2) so as not to damage any casts or cells. The 
supernatant should be decanted gently, leaving approximately 1mL of urine in which the 
sediment can be resuspended prior to microscopic examination (Sink and Weinstein, 2012). 
The correct identification of bacteria on urine sediment examination is multifactorial and can 
depend on operator experience, technique used and the number and type of bacteria present. 
It is generally reported that >104 rods/mL of urine and >105 cocci/mL must be present before 
positive identification on unstained sediment examination can be made (Reppas and Foster, 
2016b).  
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Swenson et al. (2011) compared the microscopic examination of an unstained wet preparation 
of urine sediment against a modified Wright’s stained air-dried preparation for the detection 
of bacteriuria in 472 feline urine samples obtained by cystocentesis. Twenty-nine of the urine 
samples were positive on urine culture. A superior sensitivity and specificity of 82.8% and 98.7% 
respectively were obtained with the stained air-dried technique versus a sensitivity and 
specificity of 75.9% and 56.7% respectively for the unstained wet preparation examination. 
The stained air-dried technique also improved morphological identification of bacteria which 
may aid a clinician’s choice of empiric antimicrobial treatment. This study is limited by having 
seven laboratory technicians of varying experience performing the wet preparation sediment 
examination with agreement between individual technicians ranging from 20-69.2%. 
Quantitative urine culture was used as the gold standard in this study which too is prone to 
false negative and false positive results (Reppas and Foster, 2016b, Rowlands et al., 2011). 
In a similar study, O'Neil et al. (2013) compared the microscopic examination of an unstained 
wet preparation of urine sediment against a modified Wright’s stained air-dried preparation 
and a Gram-stained preparation for the detection of bacteriuria in 111 canine and 79 feline 
urine samples obtained by cystocentesis. Eleven canine and seven feline samples had a 
positive urine culture result. In this study the authors found that Wright’s staining and Gram 
staining performed equally well in terms of sensitivity and specificity. For feline samples the 
sensitivity of all methods was equal at 85.7%. The specificity for the unstained wet preparation 
was 88.8% which increased to 98.6% by using either a Wright’s stain or Gram stain on an air-
dried sample. This study used only three laboratory technicians, which may in part explain the 
increased specificity reported for the unstained wet preparation sediment examination.  
Pyuria is generally defined a >5WBC/HPF although the definition does vary between studies 
evaluating urine sediment examinations. Pyuria may be seen with inflammatory or infectious 
processes occurring within the urinary tract and contamination from the genital tract should 
be considered if voided urine samples are being examined (Piech and Wycislo, 2018). Multiple 
studies have identified associations between pyuria and positive urine cultures but pyuria is 
not always documented in subclinical bacteriuria (Weese et al., 2019). 
In the study by Litster et al. (2009), pyuria was significantly more likely to be documented in 
cats with subclinical bacteriuria compared to culture negative controls, p<0.0001, suggesting 
the presence of bacteria still evoke an inflammatory response despite a lack of lower urinary 
tract clinical signs. Swenson et al. (2011) also identified a strong association between pyuria 
identified on unstained sediment examination and a positive urine culture, although the 
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presence or absence or lower urinary tract signs were not recorded in this study. Despite this 
association, pyuria was not documented in 66% of culture positive samples suggesting pyuria is 
an insensitive predictor of a positive culture. The authors concluded that bacteriuria should be 
confirmed by quantitative urine culture and that a lack of pyuria should not be interpreted as a 
lack of infection.  
The retrospective study by Puchot et al. (2017) agreed with this finding by reporting a strong 
association between the presence of pyuria (defined as >3WBC/HPF in this study) and 
subclinical bacteriuria, p<0.0001. Pyuria was however not recorded in 11 of 31 culture positive 
samples further demonstrating that pyuria is not always documented in cases of subclinical 
bacteriuria.  
Identification of erythrocytes can confirm that a positive result on the dipstick blood pad is due 
to haematuria rather than haemoglobinuria or myoglobinuria. Up to 5 RBC/HPF can be found 
in healthy cats and >5RBC/HPF is considered abnormal (Reppas and Foster, 2016b). There is 
currently conflicting literature regarding associations between the presence of microscopic 
haematuria and a positive urine culture.  
A retrospective study evaluating urine sediment examinations in cats presenting with lower 
urinary tract clinical signs or diagnosed with CKD, DM or uncontrolled hyperthyroidism found a 
significant association between the presence of haematuria and a positive urine culture. This 
finding was established for the study population as a whole and for each individual disease 
state (Bailiff et al., 2008). Litster et al. (2009) also identified a significant association between 
the presence of haematuria and a positive urine culture in a study of 132 cats without lower 
urinary tract clinical signs, p=0.013. 
These findings contrast with that of Puchot et al. (2017) who failed to find a significant 
association between haematuria as an individual variable and subclinical bacteriuria. Puchot et 
al. (2017) did however conclude that classifying the presence of one or more of the variables 
of haematuria, pyuria or bacteriuria as an active sediment, greatly improved the negative 
predictive value of sediment examination.  
In a prospective study of 111 cats presenting to primary care practices with clinical signs of 
lower urinary tract disease Lund et al. (2013) identified the presence of haematuria as a 
significant risk factor for lower urinary tract disease versus non-lower urinary tract disease. 
However, no significant differences between the various diagnoses of lower urinary tract 
disease were established. O'Neil et al. (2013) reported haematuria was not a useful predictor 
of positive urine culture with haematuria identified in 29% of cats with a positive culture and 
Chapter 2 - Literature Review 
14 
 
28% with a negative culture in a study evaluating urine sediment examination in 81 cats.  The 
inconsistent reports in the literature at present suggest that haematuria based on sediment 
examination should not be used to predict positive urine cultures. Interestingly, in the study by 
O'Neil et al. (2013), higher rates of false identification of bacteria occurred when haematuria 
was present.  
Struvite urolithiasis and crystalluria occurs frequently in dogs with UTI caused by urease-
producing bacteria (Dear et al., 2019). Struvite urolithiasis is often not associated with UTI in 
cats (Lulich et al., 2016), and O'Neil et al. (2013) found no association between crystalluria and 
a positive urine culture result. In the same study O'Neil et al. (2013) did identify a negative 
association between lipiduria and bacteriuria, p<0.01. This suggests that the presence of lipid 
particles on sediment examination, which is seen more commonly in cats than it is dogs, may 
obscure the accurate identification of bacteria.  
2.1.5.3 Quantitative Urine Culture 
Quantitative urine culture is considered the gold standard for diagnosing UTI and urine 
samples should be obtained for culture prior to any antimicrobial administration (Lulich and 
Osborne, 2004). Cystocentesis is the preferred method of collection for bacterial culture as this 
minimises the risk of contamination from the skin or distal genital tract flora (Rowlands et al., 
2011). Cystocentesis may not be always be possible and is contraindicated in patients with 
coagulopathies, therefore urinary catheter-obtained or voided samples may sometimes be 
submitted for urine culture (Vilhena et al., 2015). 
Urine culture should be performed within 24 hours of sample collection to reduce the risk of 
false positive results (Patterson et al., 2016). Urine samples not being submitted for immediate 
processing should be refrigerated to retard bacterial growth (Acierno et al., 2018).  
For canine urine samples, the use of the preservative boric acid is no longer recommended 
when samples are posted to external laboratories for urine culture. Rowlands et al. (2011) 
demonstrated false negative results were significantly more likely in samples that had been 
preserved with boric acid. Too few cats were included in this study to know whether the same 
effect is true for feline urine samples.  
In a retrospective study of 134 cats presented to a primary care practice with lower urinary 
tract clinical signs in Norway,  Eggertsdottir et al. (2007) reported a 33% prevalence rate of UTI. 
In this study, 26% of positive urine cultures were obtained from voided urine samples. Whilst 
this % was not significantly different from the 23% of samples obtained by cystocentesis, other 
studies have demonstrated voided urine samples can produce bacterial growths of sufficient 
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magnitude such that genuine infection, rather than contamination is diagnosed  (Lees et al., 
1984, van Duijkeren et al., 2004). The current ISCAID guidelines for the diagnosis and 
management of bacterial UTI in dogs and cats stress that cystocentesis is the preferred 
method of sample collection for urine culture (Weese et al., 2019). 
Although considered the gold standard diagnostic test, quantitative urine culture is not 
without its limitations. For example, infection with a fastidious organism may not produce a 
positive result using standard laboratory culture techniques (Reppas and Foster, 2016b). In 
human medicine, this limitation has been somewhat addressed by the introduction of 
Expanded Quantitative Urine Culture (EQUC) whereby an increased volume of urine is cultured 
using an extended range of media. The addition of EQUC in human patients with clinical signs 
of cystitis but negative standard urine cultures identified a 90% false-negative rate for 
standard culture techniques (Hilt et al., 2014, Tang, 2017). 
2.1.6 Treatment  
Urinary tract infections should be treated based on antimicrobial susceptibility testing (AST) 
(Lulich and Osborne, 2004). Given that the prevalence of UTI in cats in considered to be low, 
particularly amongst young male cats presenting with lower urinary tract clinical signs, 
empirical antimicrobial therapy is rarely indicated (Gerber et al., 2005, Sparkes, 2018, Dorsch 
et al., 2019).  
Given the current lack of prospective studies regarding subclinical bacteriuria in cats, the 
recommendations regarding treatment have largely been extrapolated from human studies 
(Weese et al., 2019). A systematic review and meta-analysis by Koves et al. (2017) identified 
surgical patients undergoing urological procedures in which the mucosal layer may bleed and 
pregnant women as the two populations in which the treatment of asymptomatic bacteriuria 
was of benefit. The review did however conclude that the evidence base for the screening and 
treatment of asymptomatic bacteriuria in pregnant woman was low and that further 
randomised controlled trials evaluating the benefit of treatment for both mother and 
developing foetus are needed. The National Institute for Health and Care Excellence (NICE) in 
the United Kingdom state pregnant women should be screened and treated for asymptomatic 
bacteriuria due to the risk of development of pyelonephritis and an increased risk of preterm 
delivery in untreated cases (NICE, 2018). For all other populations, the screening for, and 
treatment of, asymptomatic bacteriuria is discouraged due to the risk of antimicrobial therapy 
selecting for multidrug resistance (Cai et al., 2017). 
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In a prospective longitudinal study conducted over three and a half years, White et al. (2016) 
obtained urine samples by cystocentesis from a sample of 67 non-azotaemic, non-pregnant 
cats that did not display any lower urinary tract clinical signs. The population of cats belonged 
to a university breeding colony primarily used for nutritional research. In total, 28 positive 
urine cultures were obtained from 11 cats. Antimicrobials were withheld from cats diagnosed 
with subclinical bacteriuria and no significant association between subclinical bacteriuria and 
survival was identified. Due to the study population belonging to a colony of genetically 
related cats receiving identical standards of care and husbandry, it is difficult to extrapolate 
the results from this study to a wider population. Colony policies dictated any cat with chronic 
weight loss due to a disease process other than hyperthyroidism were euthanised, preventing 
any associations being made between subclinical bacteriuria and other pathology. The authors 
concluded that antimicrobial therapy for subclinical bacteriuria in non-azotaemic cats may not 
be indicated but longer studies in alternative populations of cats are needed. Data is currently 
lacking to support or discourage the use of antimicrobials for subclinical bacteriuria in cats 
with CKD (Dorsch et al., 2019). Current ISCAID guidelines state treatment ‘may be considered if 
there is a particularly high risk of ascending or systemic infection,’ although no good data exist 
defining high-risk populations (Weese et al., 2019). 
Novel treatment modalities for UTI such as the establishment of asymptomatic bacteriuria or 
subclinical bacteriuria have been the subject of clinical trials in humans and dogs respectively 
over recent years. In a double-blind placebo-controlled cross-over trial of 20 patients with 
incomplete bladder emptying, Sunden et al. (2010) demonstrated both a reduced frequency of 
UTI, and longer symptom free periods, by establishing asymptomatic bacteriuria with E. coli 
83972. This protective effect was also characterised in patients with spinal cord injury by 
Darouiche et al. (2005). 
Single and multi-dose protocols of establishing E. coli 83972 subclinical bacteriuria have been 
described in dogs with little difference in the duration of colonisation identified between 
protocols (Thompson et al., 2011, Thompson et al., 2012). Clinical trials evaluating the use of E. 
coli 83972 as an alternative to antimicrobial therapy for the treatment of UTI in dogs or cats 
have yet to be reported.  
In dogs, Segev et al. (2018) recently evaluated the use of an intravesicular infusion of an 
asymptomatic bacteriuria strain of E. coli 2-12 as an alternative to antimicrobial therapy for 
the treatment of recurrent UTI. E. coli strain 2-12 has been shown to have superior analgesic 
qualities when compared to ciprofloxacin in murine models, hence its choice over E. coli 83972 
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for this trial (Rudick et al., 2014). An initial safety study was conducted using 6 purpose-bred 
research Beagle bitches. Two infusions of E. coli were carried out on day 0 and day 8 of the 
experiment and further urine samples were obtained for culture and urinalysis by 
cystocentesis on days 1, 3, 8, 9, 11, 16 and 30. No major adverse events were reported during 
the infusion process and no dogs demonstrated any lower urinary tract clinical signs during the 
study. One dog had a positive urine culture on day 8, prior to the second infusion, of a 
Streptococcus sp. of 3x102 CFU/mL but all subsequent urine cultures were negative. Positive 
cultures of the asymptomatic bacteriuria E. coli 2-12 were observed in 4 of the 6 dogs at 
various time points but all dogs were culture negative by day 16.  
The safety study was followed by a clinical efficacy study in 9 client-owned dogs. All dogs 
displayed lower urinary tract clinical tract signs and had infections documented with the 
following bacteria: E. coli (4), Proteus spp. (3), Staphylococcus spp. (1) and co-infection of 
Proteus spp. and Staphylococcus spp. (1). Intravesicular infusion of asymptomatic bacteriuria E. 
coli 2-12 was performed on day 0 with further urine samples obtained for culture and 
urinalysis by cystocentesis on days 1, 7 and 14. Outcomes measured were clinical signs and 
bacterial growth. Microbiological cure was defined as no growth or growth of only the 
asymptomatic bacteriuria E. coli 2-12. Resolution of clinical signs was achieved in 4 dogs, 3 of 
which had microbiological cure. Microbiological cure was also documented in 2 other dogs on 
day 1, but subsequent cultures documented a reinfection with the original pathogen.  
This was the first trial evaluating the use of asymptomatic bacteriuria E. coli 2-12 for the 
treatment of recurrent UTI in dogs. Segev et al. (2018) concluded that a single intravesicular 
infusion of E. coli 2-12 was safe and that further studies exploring alternative dosing intervals 
are warranted given the promising results of this trial. This study is limited by its small sample 
size of 9 dogs and its short term follow up of 14 days in the clinical efficacy phase and so future 
work should look to address these limitations.   
Chapter 2 - Literature Review 
18 
 
2.2 URINARY PROTEOMICS 
2.2.1 Background 
The field of proteomics encompasses research techniques that serve to identify and quantify 
the proteome of a cell, tissue or entire organism (Aslam et al., 2017). The proteome of a cell is 
defined as the total protein content expressed by the genetic material at any particular time 
(Ceciliani et al., 2014). The actual proteome can differ markedly from that predicted from the 
genome of a cell due to post-translational mechanisms and so the fields of proteomics and 
genomics are considered complementary (Reusz, 2019). Proteomic techniques have provided 
advances in both diagnostics and in understanding the pathogenesis of a number of diseases, 
including urinary tract infections, by identifying novel biomarkers and identifying changes in 
host protein expression associated with diseased states respectively (Katsafadou et al., 2016, 
Floyd et al., 2015). 
2.2.2 The Urinary Proteome and Its Applications 
The canine urinary proteome was first characterised by Brandt et al. (2014). Over 500 unique 
proteins were identified from pooled urine samples of 11 healthy dogs. Three hundred and 
thirty-eight of these proteins overlapped with the human urinary proteome characterised by 
Adachi et al. (2006). Brandt et al. (2014) concluded that canine urinary proteomics may be 
utilised as a model for human disease studies in future research as many of the proteins 
common to both proteomes have been associated with specific disease states in humans. 
Despite all dogs enrolled in this study having a full physical examination, complete blood count, 
serum biochemistry profile, urinalysis and UPC measurement, the pooling of all urine samples 
is a limitation to this study as the authors were not able to determine how many urinary 
proteins were common to each dog.  
To date, feline urinary proteomic studies have largely focussed on identifying biomarkers for 
disease states such as CKD, idiopathic cystitis, UTI and urolithiasis (Ferlizza et al., 2015, Jepson 
et al., 2013, Lemberger et al., 2011, Treutlein et al., 2013).   
Ferlizza et al. (2015) compared the urinary proteome of 23 healthy cats to that of 17 cats with 
proteinuric (UPC > 0.2) CKD. Thirteen proteins were identified that differed in abundance 
between the two groups including retinol-binding protein (RBP), beta-2-glycoprotein 1 and 
cauxin, all of which have been associated with renal disease in either humans or cats (Pallet et 
al., 2014, van Hoek et al., 2009). Whilst the authors concluded that the potential biomarkers 
identified may prove useful in the diagnosis and monitoring of cats with CKD in the future, 
given that the majority of cats with CKD have a UPC <0.2, further work should investigate if  
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differences in urinary protein profiles exist between healthy cats and cats with non-proteinuric 
CKD (Bartges, 2012). 
In a prospective study, Jepson et al. (2013) used proteomic techniques to evaluate urinary 
proteins as potential biomarkers for the development of azotaemia in 20 cats. Over a 12-
month period, 10 of 20 cats developed azotaemia and eight potential urinary biomarkers were 
identified from these cats. The potential biomarkers were of low molecular weight and further 
study could permit their identification and evaluation of their function and utility as a 
biomarker for the prediction of azotaemia.  
Lemberger et al. (2011) used proteomic techniques to compare the nature and abundance of 
urinary proteins present in cats without lower urinary tract clinical signs and cats with 
idiopathic cystitis, UTI and urolithiasis. The authors concluded that fibronectin was significantly 
more abundant in the urine of cats with idiopathic cystitis compared to all other groups. 
Follow up histopathological examination, including immunohistochemical analysis, of two 
bladder biopsies from two cats with idiopathic cystitis identified reduced fluorescence for 
fibronectin compared to control cats. These findings suggest damage to bladder urothelium 
may permit leakage of fibronectin into the bladder lumen thus allowing fibronectin to serve as 
a potential biomarker for idiopathic cystitis. However, a follow up study by Treutlein et al. 
(2013) failed to find consistently elevated urinary fibronectin concentrations in a population of 
27 cats with obstructive idiopathic cystitis, questioning the utility of urinary fibronectin as a 
biomarker for this disease.  
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2.3 THE URINARY MICROBIOME 
2.3.1 Background 
In recent years it has been established that complex microbial communities exist within many 
different body sites. These communities have been termed the microbiota, whilst the genetic 
material of these microbes is referred to as the microbiome (Brubaker and Wolfe, 2016). The 
Human Microbiome Project (HMP) was established in 2008 and has started to characterise the 
microbiome of the gastrointestinal tract, the mouth, the vagina, the skin and the nasal cavity 
(HMP, 2019). Urine has traditionally been considered sterile and so the bladder was not an 
initial site of interest for the HMP (Thomas-White et al., 2016). 
The canine urinary microbiome was characterised by Burton et al. (2017) in a study designed 
to both define the urinary microbiome but also compare this to the gastrointestinal and genital 
microbiomes of the same individual. Nine male neutered, one male entire and ten female 
neutered dogs were included in the study. Exclusion criteria included: administration of 
antimicrobials, probiotics or corticosteroids within the last 30 days, administration of 
intravenous fluid therapy within the last 24 hours, clinical signs suggestive of systemic 
infection, any history of lower urinary tract clinical signs or a positive urine culture. Urine 
samples were obtained by cystocentesis. Following DNA extraction, the hypervariable region 
V4 of the 16S rRNA gene was amplified and sequenced. Analysis of only one hypervariable 
region limits taxonomic classification to the level of family or genus (Thomas-White et al., 
2016). Genera identified at >1% relative abundance included Pseudomonas spp., Sphingobium 
spp. and Acinetobacter spp.. No significant difference was found between the urinary 
microbiome of male or female dogs. The authors concluded that although some overlap 
between the three sites evaluated exists, the urinary microbiome is largely unique compared 
to that of the gastrointestinal tract and genital tract. One limitation in the study population 
selection is the lack of complete blood count, serum biochemical profile and urinalysis 
evaluation to define a healthy subject for the study. Dogs included may have suffered from 
subclinical disease, such as early stage CKD, that may influence, or be influenced by the urinary 
microbiome.  
To date, one abstract has been presented at the American College of Veterinary Internal 
Medicine (ACVIM) annual forum describing a feline urinary microbiome. Vester Boler et al. 
(2018) extracted bacterial DNA in urine samples obtained by cystocentesis from 15 healthy 
adult cats. The hypervariable region V4 of the 16S rRNA gene was amplified and sequenced. 
Taxonomic phyla identified in the samples included Proteobacteria, Firmicutes, Actinobacteria, 
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Bacteroidetes and Cyanobacteria. Genera identified varied between cats but Staphylococcus 
spp. were identified in all samples. Other genera identified included: Enterobacter spp., 
Acinetobacter spp., Streptococcus spp., and Shigella spp..  
2.3.2 Applications of Understanding the Urinary Microbiome 
The role of the urinary microbiome in diseases such as urgency urinary incontinence, neoplasia 
of the prostate or bladder wall, urolithiasis and UTI is an area of active research (Li et al., 2019).  
The diversity of the female urinary microbiome has been shown to vary according to hormone 
status. The urinary microbiome of pre-menopausal women tends to be dominated by 
Lactobacillus spp. whereas the urinary microbiome of post-menopausal women tends to be 
more diverse (Brubaker and Wolfe, 2016). A more diverse urinary microbiome has been 
associated with recurrent UTI in elderly patients and urgency urinary incontinence (Thomas-
White et al., 2017, Tang, 2017). It has been suggested that a predominance of Lactobacillus 
spp. may protect against UTI as products of their metabolism have been shown to impair E. 
coli adhesion to uroepithelial cells (Tang, 2017). Raz et al. (2003) showed that the use of 
estriol-containing vaginal pessaries reduced the frequency of clinical episodes of cystitis in 
post-menopausal women with recurrent UTI although the mechanism of this effect has yet to 
be fully elucidated.  
Clinical trials exploring Lactobacillus spp. probiotics as an alternative to antimicrobial therapy 
for UTI have yet to demonstrate acceptable efficacy, although research is likely to continue in 
this area as some benefit for prevention of recurrent UTI has been reported (Beerepoot et al., 
2012). 
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2.4 THE URINE PROTEIN-TO-CREATININE RATIO 
2.4.1 Background 
The ACVIM has defined the term proteinuria as the ‘detection of an abnormal amount of 
protein in the urine’ (Lees et al., 2005). Urine from healthy cats typically contains very little 
protein, often <1mg/dL of albumin (Grauer, 2011). Albumin is the most abundant protein 
found in the urine of the majority of proteinuric patients, but other proteins such as globulins 
and Bence-Jones proteins may also be identified due to a number of physiological or 
pathological processes (Lyon et al., 2010). A single UPC has been shown to correlate well with 
24-hour urinary protein loss in the cat which is considered the gold standard for proteinuria 
quantification (Monroe et al., 1989). The UPC therefore provides a practical and quantitative 
assessment of proteinuria for practitioners. 
2.4.2 Effects of Urine Sampling Technique 
To date, three studies have evaluated the effect the method of urine sample collection has on 
UPC measurement. Beatrice et al. (2010) and Marynissen et al. (2017), compared the UPC in 
samples obtained by cystocentesis with the UPC obtained from voided urine samples in 81 and 
74 dogs respectively. Both reported no significant difference between the UPCs obtained by 
the two methods of collection and significantly strong correlation was also identified.  
Vilhena et al. (2015) evaluated the difference in UPC obtained by cystocentesis and urine 
obtained from manual compression of the bladder in 43 cats. Significant strong correlation was 
reported between both methods of collection in both the study population as a whole, 
ρ=0.987, and for males and females separately, Pearson r2 = 0.987 and Pearson r2 = 0.987 
respectively. There are two major limitations of this study. Firstly, mean or median differences 
in UPCs obtained via different methods of collection were not calculated. Correlation alone 
does not infer agreement nor that two methods of obtaining urine for UPC measurements are 
interchangeable. Further statistical analysis of these data would be required to demonstrate 
agreement.  Secondly, urine was obtained by manual compression of the bladder which may 
not always be tolerated by cats and rarely can cause damage resulting in haematuria 
(Balakrishnan and Drobatz, 2013). Manual compression of the bladder has also been 
associated with ureteral reflux, which in cases of UTI can lead to upper urinary tract bacterial 
colonisation and so this method of urine sample is not recommended (Schaeffer, 2001, Vilhena 
et al., 2015).  
Voided urine samples in the UK are often obtained by means of a non-absorbent cat litter 
substrate such as hydrophobic sand or polypropylene beads (Delport and Fourie, 2005). It has 
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been demonstrated that polypropylene beads do not interfere with the measurement of pH, 
protein concentrations or the sediment evaluation of red and white blood cells in human urine 
(Pastoor et al., 1990). Hydrophobic sand has only been evaluated in laboratory animals to date, 
with no interference reported in the measurement of urine specific gravity, urinary dipstick 
parameters of: leukocytes, nitrites, urobilinogen, protein, pH, blood, USG, ketones, bilirubin 
and glucose and urinary creatinine and corticosterone concentrations in rats when comparing 
urine obtained from standard metabolic cages to urine collected from hydrophobic sand 
(Hoffman et al., 2018).   
Due to the day-to-day variation in urinary protein excretion, serial UPC measures are required 
to demonstrate persistence in proteinuria (Hoskins et al., 1991, Lees et al., 2005). To overcome 
the need to individually measure UPCs on serial samples, the use of 3 pooled urine samples 
has been shown to be acceptable in most situations (LeVine et al., 2010, Shropshire et al., 
2018). Where UPC values are close to clinical decision thresholds, repeated measures of serial 
urine samples are suggested (LeVine et al., 2010). 
2.4.3 The Effect of Haematuria and Pyuria on Urine Protein-to-Creatinine Ratios 
The effect that pyuria, haematuria or bacteriuria has on interpretation of UPC measurement is 
currently of debate. Studies evaluating the effect of blood contamination of urine samples vary 
in methodology and statistical analysis making direct comparisons difficult.  
In one study, Vaden et al. (2004) reported that canine urine samples with pyuria were still 
likely to have a UPC of <0.5. No correlation was evident between the degree of pyuria and 
either urinary albumin concentrations or UPC. Concurrent haematuria or bacteriuria was 
shown to increase urinary albumin concentrations but not significantly increase the UPC. 
When urine samples were contaminated to the extent that urine turned red, UPCs did not 
exceed 0.5 in this study. The authors did however conclude that given the increase in urinary 
albumin concentrations observed in visibly red urine samples, haematuria should be 
considered as a differential diagnosis for an elevated UPC in these cases.  
This contrasts with another study where 18 urine samples obtained from dogs were 
contaminated with blood from the same individual. In this study, contamination or urine with 
blood resulting in red discolouration resulted in up to 94% of samples that were initially non-
proteinuric being misclassified as either borderline proteinuric or proteinuric (Jillings et al., 
2019). 
Vientos-Plotts et al. (2018) pooled urine samples obtained from 120 cats and contaminated 
these with feline blood submitted to their laboratory. The authors reported significant 
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increases in UPC and up to 76% of samples changed category for proteinuria as defined by the 
International Renal Interest Society (IRIS) when blood contamination resulted in a colour 
change to dark yellow.   
The colour grading system in all three studies varied, which may in part explain the contrasting 
results reported. For example, in the study by Jillings et al. (2019), the authors concluded that 
if haematuria resulted in an orange urine sample, a clinically significant increase in UPC may be 
observed. In the study by Vientos-Plotts et al. (2018), orange was not part of their colour score 
and it is unclear whether samples considered orange by Jillings et al. (2019) would be 
considered dark yellow or light pink by Vientos-Plotts et al. (2018). The data from all studies 
suggest that caution should be exercised when interpreting UPCs from urine samples with 
evidence of haematuria, and to a lesser extent pyuria, and that an elevated UPC may not solely 
be attributable to post-renal causes in these cases.  
2.4.4 The Link Between Proteinuria and Urinary Tract Infections 
Current guidelines for human medicine state that due to the association between the presence 
of proteinuria and UTIs, any patient with a positive result for urinary total protein from either 
semi-quantitative or quantitative methods should have a UTI excluded by means of a urine 
culture (Carter et al., 2006). 
Associations between proteinuria and symptomatic UTIs and asymptomatic UTIs vary. Multiple 
studies have found associations between proteinuria and asymptomatic UTI in certain human 
populations, such as female type-1 diabetics and patients with nephrotic syndrome. Although 
these authors concluded that the presence of proteinuria may render these populations more 
susceptible to UTIs, causal relationships could not be established. Larger scale studies of 
healthy children and young adults failed to find any association between the presence of 
proteinuria and asymptomatic UTIs, with all authors concluding that both conditions 
frequently occur independently (Carter et al., 2006, Bharara et al., 2017). 
On the other hand, proteinuria is a common finding in patients with symptomatic UTIs. A 
recent study investigating the ability to predict a positive urine culture based on the presence 
of proteinuria in humans concluded that proteinuria alone was not a strong predictor of UTI. 
However, the negative predictive value of proteinuria was reported as 87.8%, suggesting 
assessment for proteinuria may be a useful screening test for UTI (Bharara et al., 2017). 
Several studies in cats evaluating risk factors for both feline lower urinary tract disease and 
specifically subclinical bacteriuria have failed to identify the presence of proteinuria as a risk 
factor for both diseases (Lund et al., 2013, Puchot et al., 2017). These studies used semi-
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quantitative assessments of proteinuria by use of a dipstick and sulfosalicylic acid test and it 
has yet to be evaluated whether a UPC above a certain value is associated with a UTI in cats.  
Meindl et al. (2019) evaluated the relationship between UPC in dogs with and without positive 
urine cultures and demonstrated variable changes in UPC with positive cultures. The authors 
concluded that an active urine sediment may not fully explain an elevated UPC, and that 
repeat UPC measures should be obtained upon clearance of any infection to investigate for 
other causes of proteinuria. No significant difference in UPC was found between dogs with UTI 
or subclinical bacteriuria. Interestingly in this study, 19 of 482 urine samples analysed were 
positive for bacterial growth yet had a UPC of <0.5 demonstrating that an active sediment due 
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Chapter 3  MATERIALS AND METHODS 
3.1 THE DIAGNOSTIC APPROACH TO FELINE SUBCLINICAL BACTERIURIA AND URINARY 
TRACT INFECTIONS 
3.1.1 Study Design  
A prospective observational cohort study of cats referred to the Langford Vets Small Animal 
Hospital was conducted. Aerobic urine culture, AST, urinalysis including sediment examination, 
urine protein quantification by means of UPC measurement, cytological examination and 
proteomic analysis were performed on urine samples obtained by cystocentesis or aspiration 
from a SUB device and free catch methods from the same cat and results compared and 
analysed.  The study design was reviewed and approved by The University of Bristol Research 
Ethics Committee (VIN/17/037). 
3.1.2 Study Population 
Cats referred to the Small Animal Hospital between November 2018 and June 2019 that had 
cystocentesis performed as requested by the attending clinician were included in the study. 
Collection of both a voided urine sample and cystocentesis sample were required for inclusion. 
Cats that had received antimicrobial therapy within the last 3 days were excluded from 
analysis. Where the same cat had repeat urine samples analysed, only the first sample was 
included for statistical analyses. Recruitment into the study was aided by the use of the client 
information leaflet provided in Appendix A. 
3.1.3 Data Recording 
Descriptive data collected from each cat included age, breed, sex, neuter status, body weight, 
any clinical history and nature of lower urinary tract signs, presenting clinical signs, current 
medications, specifically any recent antimicrobial therapy and any co-morbidities. The 
collection technique for obtaining each urine sample was recorded in addition to the volume 
analysed and the results of a complete urinalysis including sediment examination, UPC 
measurement, urine culture and cytological examination. The identification of each organism 
cultured from a cystocentesis sample and its AST profile were recorded. Results from 
descriptive data and all tests performed were recorded in a spreadsheet. 
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3.1.4 Sample Collection 
A minimum of 5mL of urine were required to perform urine culture, urinalysis including 
sediment examination, UPC measurement and cytological examination. Any excess volume of 
urine was retained for proteomic analysis (see section 3.2). 
3.1.4.1 Cystocentesis Samples 
All cats were either sedated or anaesthetised for cystocentesis. Cystocentesis samples were 
collected by Veterinary Specialists in Diagnostic Imaging using ultrasound guidance. Half a 
millilitre of urine was collected in to an ethylenediaminetetraacetic acid (EDTA)-containing 
tube for cytological examination. The remaining volume was collected into a sterile plastic 
universal container. All samples were refrigerated at 4°C if not being analysed immediately. All 
cystocentesis samples were sent to Langford Vets Diagnostic Laboratories and processed 
within 18 hours of collection.  
3.1.4.2 Subcutaneous Ureteral Bypass Samples 
Urine samples were obtained by aspirating from the SUB device prior to routine flushing of the 
system by a Veterinary Specialists in Diagnostic Imaging using ultrasound guidance. Volumes 
outlined in section 3.1.4.1 were used for analysis. 
3.1.4.3 Voided Samples 
Voided samples were collected by lining a litter tray with Medicat® non-absorbent 
hydrophobic sand (GlobalTech International Ltd., London, United Kingdom). Half a millilitre of 
urine was pipetted from the surface of the non-absorbent litter in to an EDTA-containing tube. 
The remaining volume was collected into a plastic conical container provided by the litter 
manufacturer. All samples were refrigerated at 4°C if not being analysed immediately. Where a 
voided sample was not collected during hospitalisation, owners were asked to collect a sample 
at home within 2 days of being discharged using the same litter and refrigerated where 
possible prior to being posted to the Langford Vets Diagnostic Laboratory. 
3.1.5 Urine Culture 
3.1.5.1 Cystocentesis Samples 
Cystocentesis samples were processed by Langford Vets Diagnostic Laboratory technicians. 
Any refrigerated samples were brought to room temperature before being cultured. Samples 
were gently mixed by inversion prior to inoculation. Using a sterilised wire loop, 5µL of urine 
were inoculated onto Columbia agar + 5% sheep blood (Oxoid Ltd., Hampshire, United 
Kingdom) and onto Cystine-Lactose-Electrolyte-Deficient (CLED) agar (Oxoid Ltd., Hampshire, 
Chapter 3 - Materials and Methods 
28 
 
United Kingdom). Blood agar plates were incubated at 37°C in 5% CO2 and CLED plates at 37°C 
in an aerobic atmosphere. Plates were examined at 24 and 48 hours post incubation. 
Quantification of bacterial growth was calculated by multiplying the number of bacterial 
colonies present on an agar plate by 200. Bacterial growth of >103 cfu/mL were deemed 
significant as per current guidelines (Weese et al., 2011). Any cultured organism was identified 
by laboratory technicians using a combination of colony morphology and standard 
microbiological techniques outlined in Table 3.1, in accordance with Langford Vets Diagnostic 
Laboratories standard operating procedure for urine bacteriology, (Quinn et al., 2011, 
ThermoFisher, 2019) and a commercial automated analyser (Vitek 2, Biomerieux, Hampshire, 
United Kingdom). Antimicrobial susceptibility testing profiles and minimum inhibitory 
concentration determination were performed using the same automated analyser. Where 
multiple organisms were cultured, all organisms were identified and individual AST performed.  
3.1.5.2 Voided Samples 
Any refrigerated samples were brought to room temperature before being cultured. Samples 
were gently mixed by inversion prior to inoculation. Using a sterilised calibrated wire loop, 5µL 
of urine were inoculated onto Columbia agar + 5% sheep blood. Plates were incubated at 37° 
in 5% CO2 and examined at 24 and 48 hours post incubation. Quantification of bacterial growth 
was calculated by multiplying the number of bacterial colonies present on an agar plate by 200.  
Bacterial growth of >104 cfu/mL were deemed significant as per current guidelines (Weese et 
al., 2011). The gross appearance of any colony growth was recorded. Agar plates of positive 
cultures from voided samples were compared to the corresponding cystocentesis sample agar 
plates and morphological similarities or differences were recorded. 
3.1.5.3 Bacteria Storage 
Where a positive urine culture was obtained, up to 6 representative colonies were stored on a 
slope of nutrient agar (Oxoid Ltd., Hampshire, United Kingdom) at room temperature for 
proteomic analysis (see section 3.2). 
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Table 3.1 Identification summary for common UTI pathogens, adapted from Langford Vets Diagnostic 
Laboratories Standard Operating Procedure for Urine Bacteriology. 
Pathogen Gram Confirmatory Tests 
Corynebacterium sp. Positive bacilli Catalase Positive 
Confirm ID with Vitek ANC 
Enterobacter sp. Negative bacilli Oxidase Negative 
Catalase Positive 
Indole Negative 
Confirm ID with Vitek GN 
Enterococcus sp. Positive cocci Aesculin Positive 
Lancefield Group D 
Escherichia coli Negative bacilli Lactose Fermenter 
Oxidase Negative 
Indole Positive 
Klebsiella sp. Negative bacilli Oxidase Negative 
Catalase Positive 
Indole Negative 
Confirm ID with Vitek GN 
Colonies often very mucoid 
Mycoplasma sp. N/A Slow growing, no cell wall 
means not visible with Gram 
stain 
Proteus sp. Negative bacilli Non-lactose Fermenter 
Catalase Positive 
Indole Negative 
Usually swarms across plate 
Confirm ID of non-swarming 
variants with Vitek GN 
Pseudomonas sp. Negative bacilli Non-lactose Fermenter 
Oxidase Positive 
Metallic sheen to colonies 
Distinct odour 
Staphylococcus sp. Positive cocci Catalase Positive 
DNase Positive 
Purple Maltose Agar Positive 
= S. aureus 
Purple Agar Negative = S. 
pseudintermedius 











3.1.6.1 Cystocentesis Samples 
3.1.6.1.a Visual and Chemical Properties: 
Any refrigerated samples were brought to room temperature and gently mixed by inversion 
prior to analysis. Visual characteristics of colour and turbidity were recorded.  One drop of 
uncentrifuged urine was used to determine USG using a refractometer (Clinical Refractometer 
T2-NE, Atago Corporation Ltd., Tokyo, Japan). Urine pH was determined by using a benchtop 
pH meter (Checker®, Hanna Instruments Ltd., Bedfordshire, United Kingdom). Chemical 
analysis was performed semi-quantitatively using Multistix 10SG dipsticks (Siemens Healthcare 
Diagnostics Ltd., Surrey, United Kingdom) and measurements of glucose, bilirubin, ketones and 
blood were recorded by an automatic analyser (Clinitek Status +, Siemens Healthcare 
Diagnostics Ltd., Surrey, United Kingdom).   
Semi-quantitative measures obtained from dipstick readings were converted to a score for 
statistical analysis as shown in Table 3.2-Table 3.5.  
Table 3.2: Scoring chart for glucose measurement obtained by dipstick analysis. 
*From Siemens Healthcare Diagnostics, UK. 
Glucose range (mmol/L) Dipstick Result* Score 
0 Negative 0 
≥5.5 Trace 0.5 
≥14 + 1 
≥28 ++ 2 
≥55 +++ 3 
≥111 ++++ 4 
 
Table 3.3: Scoring chart for bilirubin measurement obtained by dipstick analysis. 
*From Siemens Healthcare Diagnostics, UK. 
Bilirubin Dipstick Result* Score 
No range specified Negative 0 
No range specified + 1 
No range specified ++ 2 
No range specified +++ 3 
 
  
Chapter 3 - Materials and Methods 
31 
 
Table 3.4: Scoring chart for ketone measurement obtained by dipstick analysis. 
*From Siemens Healthcare Diagnostics, UK. 
Ketones range (mmol/L) Dipstick Result* Score 
0 Negative 0 
≥0.5 Trace 0.5 
≥1.5 + 1 
≥4 ++ 2 
≥8 +++ 3 
≥16 ++++ 4 
 
Table 3.5: Scoring chart for blood/erythrocyte measurement obtained by dipstick analysis. 
*From Siemens Healthcare Diagnostics, UK. 
**Adapted from Vientos-Plotts et al. (2018). 
Blood range (~Ery/µL) Dipstick Result* Score** 
0 Negative 0 
≥10 – Non-haemolysed Trace 0.25 
≥80 – Non-haemolysed ++ 2 
≥10 – Haemolysed Trace 0.5 
≥25 – Haemolysed + 1 
≥80 – Haemolysed ++ 2 
≥200 – Haemolysed +++ 3 
 
3.1.6.1.b Urine Protein-to-Creatinine Measurement: 
Five millilitres of urine were centrifuged in a conical tube at 438rcf (1500rpm) for 5 minutes. 
The supernatant was used to determine the UPC using an automated commercial analyser 
(KoneLab 60i Prime, Thermo Fisher Scientific Ltd., Leicestershire, United Kingdom). The 
analyser utilises a pyrogallol red method and an enzymatic method to determine urinary 
protein and creatinine concentrations respectively (Thermo Scientific, 2014a; Thermo Scientific, 
2014b). 
Briefly, pyrogallol red molybdate complexes bind to proteins present in a sample. The colour 
intensity of the pyrogallol-protein complexes is directly proportional to the initial 
concentration of protein present in the sample and is measured photometrically at 600nm.  
Sarcosine is produced from creatinine with creatininase and creatinase acting as catalysts. 
Sarcosine oxidase then converts sarcosine to glycine, formaldehyde and hydrogen peroxide. 
Hydrogen peroxide reacts with 4-aminophenazone and 2, 4, 6-triiodo-3-hydroxybenzoic acid to 
produce a quinone imine chromogen with peroxidase as a catalyst. The colour intensity of the 
chromogen is directly proportional to the initial concentration of creatinine present in the 
sample and is measured photometrically at 540nm. Urine creatinine concentrations are 
converted from mmol/L to mg/dL by the formula shown in Figure 3.1. The UPC is calculated by 
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dividing the protein concentration in mg/dL by the creatinine concentration in mg/dL as shown 













3.1.6.1.c Sediment Examination 
The urine sediment was re-suspended in 1mL of supernatant by gentle pipetting. One drop of 
suspended sediment was placed in to 6.6µL containing well (KOVA Slide II with Grid, Hycor 
Biomedical Incorporation, California, USA) and was examined at low power (x100) for the 
presence of casts and at high power (x400) for the presence of cells, bacteria, crystals and 
other components. Ten random representative fields were examined and the average number 
of components present were recorded as a score as outlined in Table 3.6 and Table 3.7. The 
presence of pyuria or haematuria was also recorded as shown in Table 3.6. The presence of 
bacteriuria was recorded where ≥1 bacterium were observed. Where <1ml of urine remained 
to re-suspend the sediment, components were recorded as either present or absent.  
Table 3.6: Scoring chart for visualisation of white and red blood cells on sediment and cytological examination of 
urine sediment. 
WBC/RBC count / 
HPF 
Qualitative Score Numerical Score Pyuria/Haematuria 
0 Negative 0 0 (No) 
<5 Scant 0.5 0 
5-20 + 1 1 (Yes) 
21-100 ++ 2 1 
>100 +++ 3 1 
Uncountable ++++ 4 1 
 
  
Creatinine (mmol/L) x 1000      =        Creatinine (mg/dL) 
       88.4 
UPC = Protein concentration (mg/dL)     . 
            Creatinine concentration (mg/dL) 
Figure 3.1: Formula to convert creatinine concentrations from mmol/L to mg/dL. 
Figure 3.2: Formula for calculation of the urine protein-to-creatinine ratio (UPC). 
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Table 3.7: Scoring chart for visualisation of epithelial cells or bacteria on sediment and cytological examination of 
urine sediment. 
Epithelial Cell/Bacteria 
count / HPF 
Qualitative Score Numerical Score 
0 Negative 0 
<5 Scant 0.5 
5-20 + 1 
21-100 ++ 2 
>100 +++ 3 
Uncountable ++++ 4 
3.1.6.1.d Cytological Examination 
Slides for cytological examination were prepared using a Cytospin 4 ™ centrifuge (Thermo 
Fisher Scientific UK Ltd., Leicestershire, United Kingdom). Four drops of urine preserved in 
EDTA tubes were centrifuged at 254 rcf, medium acceleration for 5 minutes. Prepared slides 
were stained semi-automatically with a Modified Wright-Giemsa stain using a Hematek 3000 
SlideStainer (Siemens Healthcare GmbH, Erlangen, Germany). Ten random representative 
fields were viewed at low power (x100) for the presence of casts or large artefacts and at high 
power (x500) with oil immersion for the presence of cells, bacteria and other components. The 
average number of individual components present were recorded as a score as outlined in 
Table 3.6 and Table 3.7. 
3.1.6.2 Voided Samples 
3.1.6.2.a Visual and Chemical Properties 
Visual characteristics and chemical analysis were recorded as described for cystocentesis 
samples in section 3.1.6.1.a. 
3.1.6.2.b Urine Protein-to-Creatinine Measurement 
Urine protein-to-creatinine ratios were determined as described for cystocentesis samples in 
section 3.1.6.1.b. 
3.1.6.2.c Sediment Examination 
One drop of re-suspended sediment was placed on to a glass slide and covered with a coverslip. 
Ten random representative fields were examined and components quantified at low power 
and high-power magnification as described for cystocentesis samples in section 3.1.6.1.c. 
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3.1.6.2.d Cytological Examination  
Slides for cytological examination were prepared as described for cystocentesis samples in 
section 3.1.6.1.d. Prepared slides were manually stained using a commercial Romanowsky 
stain as per the manufacturer’s guidelines (Rapi-Diff II Stain, Atom Scientific, Cheshire, United 
Kingdom).  
3.1.7 Statistical Analysis 
Statistical analyses were performed using a commercially available software package (IBM 
Corporation. Released 2016. IBM SPSS Statistics for Windows, Version 24.0. Armonk, New York: 
United States of America). All non-categorical data were assessed for normality of distribution 
using the Shapiro-Wilk test. For all analyses, statistical significance was set at p<0.05. 
3.1.7.1 Sample Size Calculation 
The proportion of cats with UTI and subclinical bacteriuria was set at 0.3 and 0.05 respectively. 
With significance levels of alpha = 0.05 and beta = 0.2, 35 cats per group were needed (Clincalc, 
2019).  
3.1.7.2 Descriptive Statistics 
Descriptive variables described in section 3.1.3 were reported as counts with medians and 
ranges where appropriate. Individual associations between any historic signs, or current 
presence of, lower urinary tract signs and positive urine cultures were to be assessed using a 
Fisher’s exact test. Cats classified as having either a urinary tract infection, subclinical 
bacteriuria or negative culture were reported as counts and differentiated by method of 
collection.  
3.1.7.3 Urine Culture 
3.1.7.3.a Cystocentesis Samples 
The identity of each organism cultured and AST were reported when requested by the 
attending clinician. 
3.1.7.3.b Voided Samples 
Bacterial colony morphological differences between discordant paired samples were described. 
3.1.7.4 Urinalysis 
Differences in urinalysis parameters between cats with UTI and cats with subclinical bacteriuria 
were to be assessed by Fisher’s exact test.  




Cats with positive urine cultures were followed until the end of the study period (September 
2019) by reviewing clinical records of hospital visits on a monthly basis between the date of 
enrolment and study end date. Occurrence of clinical signs, the results of follow up urine 
cultures and any prescribed treatments were reported where available.    
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3.2 PROTEOMIC ANALYSIS 
3.2.1 Study Design 
Proteomic analysis by means of sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) coupled with liquid chromatography and tandem mass spectrometry (LC-MS/MS) 
technology of urine sediments and cultured bacteria were performed to determine whether a 
biomarker of bacterial infection and/or inflammation could be identified. 
3.2.2 Study Population 
Cats recruited as described in section 3.1.2 where excess urine was available were used for this 
study. This study was performed in two runs. Stored bacteria as described in section 3.1.5 
were also analysed. Paired urine samples were not required for this study.  
3.2.2.1 Urine Sediments 
3.2.2.1.a First Run 
Samples from cats with a history of lower urinary tract signs or positive urine cultures were 
analysed first to test the methods being used. 
3.2.2.1.b Second Run 
Following the acquisition of acceptable data, the remainder of urine samples available 
irrespective of clinical signs or culture status were analysed. Two samples of deionised water 
processed in a similar manner to all urine samples were also analysed as control samples on 
two occasions. 
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3.2.3 Sample Collection 
3.2.3.1 Urine Sediments 
Up to 5mL of excess urine were centrifuged at 329 rcf for 5 minutes in a conical tube. The 
supernatant was removed and 30µL of deionised water and 10µL of non-reducing 4X SDS 
sample buffer (Alfa Aesar, Massachusetts, USA) were added to the centrifuged pellet. These 
were stored at -20°C until electrophoresis was performed in batches.  
3.2.3.2 Bacteria 
Stored bacteria were inoculated onto nutrient broth agar plates to give single colonies and 
cultured overnight at 37°C. Four to six were selected and sub-cultured in 10mL nutrient broth 
medium and shaken with agitation overnight at 37°C. One-hundred microlitres of the 
overnight culture samples were diluted 1:10 with nutrient broth medium (Oxoid Ltd., 
Hampshire, United Kingdom) and further adjusted to give an initial optical density (OD) 600nm 
of 0.1 in 50mL nutrient broth. These were incubated for approximately 2 hours until an OD 
600nm of 0.6-0.8 was reached indicative of the log phase of bacterial growth. Samples were 
centrifuged at 4500rpm for 10 minutes at 4°C, supernatants were discarded, and pellets kept 
on ice.  
Pellets were resuspended in 30mL of 30mM Tris-hydrochloride pH 8 buffer prior to sonication 
on ice using a cycle of 1 second on, 1 second off at an amplitude of 63% for 3 minutes by a 
Sonics Vibracell VC-505TM (Sonics and Materials Incorporated, Connecticut, USA). Sonicated 
samples were ultra-centrifuged at 8000rpm for 20 minutes at 4°C. 
3.2.4 Separation by Electrophoresis 
3.2.4.1 Urine Sediments and Deionised Water 
Samples were thawed prior to separation by SDS-PAGE as described by Calvopina et al. (2017) 
using an 11% acrylamide and 0.5% bis-acrylamide gel with a 3000X1 Mini-Protean Tetra Cell 
system (Biorad Laboratories Incorporation, California, USA). Twenty microlitres of combined 
sample and SDS sample buffer were loaded into each well. Gels were resolved at 180V until 
each sample had moved approximately 1cm into the separating gel. All gels were stained with 
Instant Blue dye for a minimum of 30 minutes before being destained with water.  
3.2.4.2 Bacteria 
One microgram of protein was loaded in to a well for electrophoresis as described for urine 
sediment samples in section 3.2.4.1. 
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3.2.5 Liquid Chromatography and Tandem Mass Spectrometry 
Prepared gels were analysed by the University of Bristol Proteomics Facility using LC-MS/MS  
technology as follows: 
The 1 cm of gel lane was subjected to in-gel tryptic digestion using a DigestPro automated 
digestion unit (Intavis Ltd).  The resulting peptides from each gel fragment were fractionated 
separately using an Ultimate 3000 nanoHPLC system in line with an LTQ-Orbitrap Velos mass 
spectrometer (Thermo Scientific). In brief, peptides in 1% (v/v) formic acid were injected onto 
an Acclaim PepMap C18 nano-trap column (Thermo Scientific). After washing with 0.5% (v/v) 
acetonitrile plus 0.1% (v/v) formic acid, peptides were resolved on a 250 mm × 75 μm Acclaim 
PepMap C18 reverse phase analytical column (Thermo Scientific) over a 150 min organic 
gradient, using 7 gradient segments (1-6% solvent B over 1 min, 6-15% B over 58 min, 15-32% 
B over 58 min, 32-40% B over 5 min, 40-90% B over 1 min, held at 90% B for 6 min and then 
reduced to 1% B over 1 min) with a flow rate of 300 nL/min.  Solvent A was 0.1% formic acid 
and Solvent B was aqueous 80% acetonitrile in 0.1% formic acid. Peptides were ionized by 
nano-electrospray ionization MS at 2.1 kV using a stainless-steel emitter with an internal 
diameter of 30 μm (Thermo Scientific) and a capillary temperature of 250°C. Tandem mass 
spectra were acquired using an LTQ-Orbitrap Velos mass spectrometer controlled by Xcalibur 
2.1 software (Thermo Scientific) and operated in data-dependent acquisition mode. The 
Orbitrap was set to analyse the survey scans at 60,000 resolution (at m/z 400) in the mass 
range m/z 300 to 2000 and the top twenty multiply charged ions in each duty cycle selected 
for MS/MS in the LTQ linear ion trap. Charge state filtering, where unassigned precursor ions 
were not selected for fragmentation, and dynamic exclusion (repeat count, 1; repeat duration, 
30 s; exclusion list size, 500) were used. Fragmentation conditions in the LTQ were as follows: 
normalized collision energy, 40%; activation q, 0.25; activation time 10 ms; and minimum ion 
selection intensity, 500 counts.Protein Identification. 
3.2.5.1 Urine Sediments and Deionised Water 
The raw data files were processed and quantified using Proteome Discoverer software v1.4 
(Thermo Scientific) and searched against the UniProt Felis catus database using the SEQUEST 
algorithm or against the SwissProt Eubacteria database using the Mascot algorithm. Peptide 
precursor mass tolerance was set at 10 ppm, and MS/MS tolerance was set at 0.8 Da. Search 
criteria included carbamidomethylation of cysteine (+57.0214) as a fixed modification and 
oxidation of methionine (+15.9949) as a variable modification. Searches were performed with 
full tryptic digestion and a maximum of 1 missed cleavage was allowed. The reverse database 
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search option was enabled, and all peptide data was filtered to satisfy false discovery rate (FDR) 
of 5 %. 
3.2.5.2 Bacteria 
Raw data files were quantified as for urine sediments in section 3.2.5.1 but only a search 
against the SwissProt Eubacteria database was performed.  
3.2.6 Data Analysis 
3.2.6.1 Urine Sediments 
Proteins identified based on fewer than 3 peptide matches were excluded from analysis. The 
relative abundance for feline proteins identified was calculated by dividing the abundance of 
an individual protein by the abundance of albumin.  
Differential expression of proteins according to method of collection, presence or absence of 
clinical signs and positive or negative culture status were reported. 
3.2.6.2 Bacteria 
Proteins identified based on fewer than 3 peptide matches were excluded from analysis. The 
identity of bacterial proteins identified were recorded. The nature of bacterial proteins were 
compared to the identity of the cultured organism based on techniques outlined in section 
3.1.5. 
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3.3 THE EFFECT OF NON-ABSORBENT HYDROPHOBIC SAND LITTER ON URINE PROTEIN-
TO-CREATININE MEASUREMENTS 
3.3.1 Study Design 
A method comparison study evaluating the effect of the non-absorbent hydrophobic sand 
litter Medicat®  on feline UPC measurements was conducted. Paired UPC measures were 
obtained from urine samples at baseline and after 24 hours contact with non-absorbent litter 
and results compared any analysed. The study was conducted in 3 stages.   
3.3.2 Study Population 
Urine samples obtained by cystocentesis as described in section 3.1.4.1 or submitted to the 
Diagnostic Laboratory from surrounding veterinary practices and marked as urine samples 
obtained by cystocentesis were collected between February and July 2019. 
3.3.3 Data Recording 
Descriptive data collected from each cat included age, breed, sex and neuter status. The 
starting volume and volume recovered for each sample was recorded. Sediment examinations 
were performed and classified as active or inactive. Active sediments were described as the 
presence of >5 RBC/HPF or >5 WBC/HPF or the presence of bacteriuria. 
3.3.4 Experiment 1 – Pilot Investigation 
Thirty-five urine samples obtained by cystocentesis were used. Samples were obtained 
between February and May 2019 and stored at 4°C until the time of the experiment. Baseline 
UPCs were measured in duplicate as described in section 3.1.6.1.b and 3mL of urine were 
placed into a Petri dish containing 20g of non-absorbent litter. Sediment examinations were 
performed and classified as either active or inactive. Repeat UPC measures were to be 
obtained in duplicate after 24 hours contact with the non-absorbent litter. 
3.3.5 Experiment 2 – 15 Samples 
Sufficient volume of 15 samples remained permitting modification of experimental design and 
investigations to continue. Baseline UPC measurements in the pilot experiment were used for 
this investigation. Samples had remained stored at 4°C for 2 days prior to restarting the 
experiment. Up to 3mL (range, 1.5-3.0mL) of urine were placed into a Petri dish containing a 
reduced amount of 4g of non-absorbent litter, covered and left for 24 hours. Urine was 
recovered using a pipette and repeat UPCs measured in duplicate. The IRIS category of 
proteinuria at baseline and 24 hours was also recorded.  
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3.3.6 Experiment 3 – 25 Samples 
Twenty-five urine samples obtained by cystocentesis from 24 cats were analysed. Samples 
were submitted to the Diagnostic Laboratory either from the Small Animal Teaching Hospital 
or surrounding veterinary practices between May and July 2019. Samples were stored at -80°C 
until the time of the experiment where samples were thawed for 1 hour and mixed by 
inversion. Baseline UPC measurements were obtained in duplicate. Up to 3mL (range, 2.5-
3.0mL) of urine were placed into a Petri dish containing 4g of non-absorbent litter, covered 
and left for 24 hours. Urine was recovered using a pipette and repeat UPCs measured in 
duplicate. Sediment examinations were performed at 24 hours. The IRIS category of 
proteinuria at baseline and 24 hours was also recorded. 
3.3.7 Statistical Analysis 
Statistical analyses were performed using commercially available software packages (IBM 
Corporation. Released 2016. IBM SPSS Statistics for Windows, Version 24.0. Armonk, New York, 
USA and GraphPad Prism version 8.00 for Windows, GraphPad Software, La Jolla, California, 
USA). All non-categorical data were assessed for normality of distribution using the Shapiro-
Wilk test. For all analyses, statistical significance was set at p<0.05. 
3.3.7.1 Experiment 1 – Pilot Investigation 
Descriptive variables described in section 3.3.3 were to be reported as counts. The volume 
recovered from each Petri dish were to be reported as a mean and range. Median differences 
in UPC measures and individual components of the ratio were to be assessed using the 
Wilcoxon signed-rank test. Cohen’s kappa method was to be used to measure agreements 
between IRIS categories at 0 and 24 hours. 
3.3.7.2 Experiment 2 and 3 
Results from experiments 2 and 3 were combined and analysed together. 
Descriptive variables described in section 3.3.3 were reported as counts. The mean and range 
of volumes recovered from each Petri dish were reported. Median differences in UPC and 
individual components of the ratio were assessed using the Wilcoxon signed-rank test or sign 
test where appropriate based on visual assessment of a histogram of difference in measures. 
Mean changes in urinary protein and creatinine concentrations and UPC were reported as 
absolute values and absolute percentage changes.  
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Correlation between UPC measurements at baseline and 24 hours was assessed using 
Spearman rank-order correlation. Regression analysis was performed using Passing-Bablok 
regression and acceptability of using 24-hour samples was assessed using a Bland-Altman plot. 
Cohen’s kappa method was used to measure agreements between IRIS categories for 
proteinuria at 0 and 24 hours.  
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3.4 THE EFFECT OF URINE SAMPLE COLLECTION TECHNIQUE ON COMMON URINALYSIS 
PARAMETERS 
3.4.1 Study Design 
A study comparing measurements of USG, urine pH, UPC, dipstick parameters (pH, glucose, 
bilirubin, ketones, blood), urine sediment examination findings, cytological examination 
findings and growth on urine culture between samples obtained by cystocentesis and voided 
methods was conducted.  
3.4.2 Study Population 
The population of cats recruited in section 3.1.2 were used for this study. An additional 
inclusion criterion of paired sampled being obtained within a 24-hour time period was applied 
to this investigation.  
3.4.3 Data Recording 
Results of a full urinalysis including sediment examination, UPC measurement, cytological 
examination and urine culture were recorded for each method of collection.  
3.4.4 Procedures 
All procedures were performed with the same methods described in section 3.1.5 and 3.1.6. 
3.4.5 Statistical Analysis 
Statistical analyses were performed using commercially available software packages (IBM 
Corporation. Released 2016. IBM SPSS Statistics for Windows, Version 24.0. Armonk, New York, 
USA and GraphPad Prism version 8.00 for Windows, GraphPad Software, La Jolla, California, 
USA). All non-categorical data were assessed for normality of distribution using the Shapiro-
Wilk test. For all analyses, statistical significance was set at p<0.05. 
3.4.5.1 Urine Specific Gravity 
Median differences between USG depending on method of collection were assessed using the  
Wilcoxon signed-rank test or sign test where appropriate. Descriptions of the change in USG 
depending on method of collection were reported.  
3.4.5.2 pH 
Median differences between pH depending on method of collection were assessed using the  
Wilcoxon signed-rank test or sign test where appropriate. Descriptions of the change in pH 
depending on method of collection were reported.  
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3.4.5.3 Urine Protein-to-Creatinine Ratio 
Median differences between UPC depending on method of collection were assessed using the  
Wilcoxon signed-rank test or sign test where appropriate. The mean change in urinary protein 
and creatinine concentrations and UPC measurements were reported as integers and 
percentage changes. Correlation between UPC measurements obtained by cystocentesis and 
voided methods was assessed using Spearman rank-order correlation. Regression analysis was 
performed using Passing-Bablok regression and acceptability of using voided samples was 
assessed using a Bland-Altman plot. Cohen’s kappa method was used to measure agreements 
between IRIS categories for proteinuria between samples obtained by cystocentesis and 
voided methods.  
Passing-Bablok analysis, Bland-Altman plots and Cohen’s kappa measures of agreement were 
performed for all samples and then separately for urine samples with active and inactive 
sediments.  
3.4.5.4 Dipstick Parameters 
Semi-quantitative measures obtained from dipstick readings were converted to a score for 
statistical analysis as shown in Table 3.2-Table 3.5. The number and nature of discordant 
paired samples were reported.   
3.4.5.5 Sediment and Cytological Examination 
The average number of components identified in 10 random representative fields were 
recorded as a score as outlined in Table 3.6-Table 3.7. The presence or absence of pyuria, 
haematuria (as outlined in Table 3.6) or bacteriuria were also recorded. Median scores and 
ranges for each variable were reported as well as descriptions of changes observed in each 
variable depending on method of collection.  
3.4.5.6 Urine Culture 
McNemars test was used to determine if there was a significant difference between method of 
collection for any bacterial growth and any significant bacterial growth (i.e. >103 cfu/mL for 
cystocentesis samples and >104 cfu/mL for voided samples). The number of cases in which any, 
and significant, bacterial growth for each method of collection were reported. Where positive 
cultures were obtained, bacterial colony morphology and suspected organism identity were 
reported. 
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Chapter 4  RESULTS 
4.1 THE DIAGNOSTIC APPROACH TO FELINE SUBCLINICAL BACTERIURIA AND URINARY 
TRACT INFECTIONS 
4.1.1 Study Population 
Eighty-seven cats had cystocentesis performed as part of their medical investigations during 
the study period. Thirty-one cats were excluded from analysis for either recently receiving 
antimicrobials (n=3), already being enrolled in the study (n=2) or not being able to collect a 
voided sample (n=26). Fifty-six cats met all inclusion criteria hence the results of 112 urinalyses 
were available for analysis as outlined in Figure 4.1.  
  





Figure 4.1: Flow chart showing how cats were included in the study and how their urine samples were categorised 
based on method of collection and urine culture result. In the upper half of the figure, n= number of cats. In the 
lower half of the figure n= number of urine samples. 
(FC) – Free catch sample, (C) – Cystocentesis or Subcutaneous bypass system sample. 
LUT – Lower urinary tract. 
*Urinary tract infection and subclinical bacteriuria are only considered possible in these cases as samples 
obtained by cystocentesis are required by definition for these categories (Weese et al., 2019) 
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Median age at the time of enrolment was 11.5 years (range, 1-18). Of the 56 cats, 28 were 
male and 28 were female. All cats were neutered. Forty-one (73%) cats were domestic 
shorthair cats, 6 (11%) were domestic longhair cats and 1 of each of the following breeds were 
recruited: domestic medium hair, Bengal, Bengal-cross, British shorthair, Burmese, Maine 
Coon, Persian, Persian-cross and Tiffany. Table 4.1 shows the numbers of cats enrolled 
stratified by gender and age category. 
Table 4.1: Gender and life stage of the study population. 
*From International Cat Care, 2017.  














Male 3 1 5 16 3 28 
Female 0 4 5 16 3 28 
Total 3 5 10 32 6 56 
 
The most common reason for presentation was to assess the suitability of radioactive iodine 
(RAI) treatment for feline hyperthyroidism. The reason for presentation or final diagnosis 
reached in all recruited cats are presented in Table 4.2. 
Table 4.2: : The reason for presentation or final diagnosis of the 56 cats enrolled in the study. 
RAI – Radioactive iodine, SUB – Subcutaneous ureteral bypass system, CNS – Central nervous system. 
Reason for presentation Number of cats (%) 
Assessment for RAI treatment 36 (64.3) 
SUB device flush 4 (7.1) 
Anaemia 2 (3.6) 
Abdominal distension 1 (1.8) 
Aspiration pneumonia 1 (1.8) 
Chronic kidney disease 1 (1.8) 
CNS Lymphoma 1 (1.8) 
Constipation 1 (1.8) 
Diabetes mellitus 1 (1.8) 
Diabetic ketoacidosis 1 (1.8) 
Haematuria 1 (1.8) 
Hypercalcaemia 1 (1.8) 
Lethargy and inappetence 1 (1.8) 
Pancreatitis 1 (1.8) 
Thyroid carcinoma 1 (1.8) 
Ureteric obstruction 1 (1.8) 
Vomiting 1 (1.8) 
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Voided urine samples were obtained first in 37 cases. Cystocentesis or SUB device samples 
were obtained first in 19 cases (16 cystocentesis and 3 SUB device samples). The median time 
delay between collecting paired samples was 11 hours (range, 1 to 2160 hours). One voided 
sample was collected by an owner at home and posted to the Diagnostic Laboratory, the 
remainder were collected within the hospital. 
Fifteen cats (27%) had lower urinary tract clinical signs described in their medical histories. Up 
to 8 cats (14.3%) displayed lower urinary tract clinical signs at the time of urine sampling. One 
cat had no lower urinary tract clinical signs at presentation for a SUB device flush but 
subsequently developed pollakiuria within 24 hours of being discharged; the voided urine 
sample was obtained whilst pollakiuria was present.  
Periuria and haematuria were each reported as the only clinical sign in 2 cats. Haematuria was 
also reported in conjunction with stranguria and pollakiuria in 1 cat. Pollakiuria and dysuria 
were each reported as the only clinical sign in 1 cat.  
As outlined in Table 4.3, of the 7 cats that displayed lower urinary tract clinical signs at the 
time of obtaining cystocentesis or SUB device urine samples, 0 had a positive urine culture. Of 
the 49  cats without lower urinary tract clinical signs, 1 was found to have a positive urine 
culture.  
As outlined in Table 4.4, of the 8 cats that displayed lower urinary tract clinical signs at the 
time of obtaining voided urine samples, 3 (37.5%) were found to have a positive urine culture. 
Of the 48 cats without lower urinary tract clinical signs, 3 (6.2%) were found to have a positive 
urine culture. There was a statistically significant association between the presence of lower 
urinary tract clinical signs and a positive urine culture, p=0.032.  
Table 4.3: Frequencies of cats presenting with or without LUT signs at the time of cystocentesis or SUB device 
sampling and the respective urine culture status. 
LUT – Lower urinary tract, SUB – Subcutaneous ureteral bypass system. 
Current LUT clinical signs / 
Culture status  
Culture positive Culture negative 
LUT clinical signs present 0 7 
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Table 4.4: Frequencies of cats presenting with or without LUT signs at the time of free catch urine sampling and 
the respective urine culture status. 
LUT – Lower urinary tract, SUB – Subcutaneous ureteral bypass system. 
Current LUT clinical signs / 
Culture status  
Culture positive Culture negative 
LUT clinical signs present 3 5 
LUT clinical signs absent 3 45 
 
The study group assigned to each cat (i.e. negative, subclinical bacteriuria or urinary tract 
infection) based on urine culture result varied depending on method of sample collection. 
Study group assignment differentiated by method of collection is outlined in Table 4.5. 
Table 4.5: Study group assignment differentiated by urine sample method of collection. 
SUB – Subcutaneous ureteral bypass system. 
Method of 












55 1 0 0 
Free catch 
 
50 1 2 3 
 
 
4.1.2 Subclinical Bacteriuria 
4.1.2.1 Cystocentesis Samples 
One cat was diagnosed with subclinical bacteriuria based upon a positive urine culture 
obtained from a SUB device urine sample and is hereafter referred to as ‘Cat A’. Cat A was an 
8-year female neutered domestic longhair weighing 3.2kg and was presented for a routine 
flush of a SUB device that had been placed 30 months prior due to nephrolithiasis. An isolate 
of Enterococcus faecalis susceptible to clavulanate-potentiated amoxicillin and ampicillin, 
intermediate susceptibility to enrofloxacin and marbofloxacin and resistant to penicillin G had 
been cultured at the time of the SUB device placement.  
The SUB device was flushed with taurolidine three months post-placement due to persistence 
of E. faecalis infection. The subsequent urine culture documented a Staphylococcus aureus 
isolate susceptible to erythromycin and trimethoprim/sulphonamide, intermediately 
susceptible to enrofloxacin and resistant to clindamycin, cefoxitin, gentamicin and penicillin G.  
Enterococcus spp. were documented at the subsequent SUB device flush 3-months later and 
persisted until the end of the study period. This isolate was susceptible to clavulanate-
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potentiated amoxicillin, ampicillin and nitrofurantoin and intermediately susceptible to 
enrofloxacin and trimethoprim/sulphonamide.  
Co-morbidities at the time of presentation included CKD (IRIS stage II, non-hypertensive 
[treating] and proteinuric [treating]) and hypercalcaemia (total calcium 3.58mmol/L [ref: 2.3-
2.5] and ionised calcium 1.55mmol/L [ref: 1.1-1.4]). Current medications included amlodipine 
as well as being fed a prescription renal diet.  
Notable urinalysis results obtained from the SUB device sample and voided sample are 
presented in Table 4.6. The voided sample was collected 12 hours after the SUB device sample. 
The urine culture from the SUB device sample documented a pure growth of Enterococcus spp. 
The predominant organism cultured from the voided sample looked morphologically similar to 
the Enterococcus spp. with smaller growths of yellow colonies also documented. A comparison 
of the blood agar plates can be seen in Figure 4.2. 
 
Table 4.6: Comparison of SUB device and free catch urinalyses results for Cat A. 
Parameter / Method of 
collection 
SUB device sample Voided sample 
USG  1.016 1.018 
pH (pH meter) 6.4 6.2 
UPC 1.04 0.84 
Dipstick analysis 
Blood +++ +++ 
Sediment examination 
White blood cells ++ +++ 
Red blood cells +++ +++ 
Bacteria ++ +++ 
Calcium phosphate crystals Scant - 
Cytology examination 
White blood cells +++ ++++ 
Red blood cells +++ +++ 
Bacteria ++++ ++++ 
Urine culture 
Quantity Profuse Profuse 
Purity Pure Mixed 
Species / Morphology Enterococcus spp. Profuse growth of small grey 









Figure 4.2: A comparison of the blood agar plates cultured from Cat A. 
Left – SUB device sample. A pure growth of Enterococcus spp. was identified.  
Right – Free catch sample. Note the similarity in morphology of the grey colonies with the additional scant 
growth of larger yellow colonies.  
 
4.1.2.2 Voided Samples 
Three cats were diagnosed with subclinical bacteriuria based upon positive urine cultures 
obtained from voided samples. One sample was from Cat A described in section 4.1.2.1. Two 
urine culture results from voided samples were discordant with corresponding cystocentesis 
samples.  
The two additional cats were domestic shorthair cats aged between 13 and 15 years. Both cats 
were female and neutered and were presented for assessment of suitability for RAI treatment. 
Urine samples were collected in the hospital with a time delay between obtaining paired 
samples of 6 and 1512 hours. Both cats had no prior history of lower urinary tract clinical signs 
reported.  
‘Cat B’ was female neutered and weighed 3.6kg. Chronic kidney disease (IRIS Stage I borderline 
proteinuric, pre-hypertensive) was documented at the time of presentation. Urine samples 
were collected 6 hours apart with the voided sample obtained first. Voided urine remained in 
the litter tray for approximately 5 hours prior to collection and analysis. Glucosuria was 
documented on the voided urine sample (result: ‘++’) but not on the cystocentesis sample. 
Bacteriuria on sediment exam was documented to be ‘scant’ and ‘+’ on voided and 
cystocentesis samples respectively. Cytological examination documented bacteria on the 
voided sample only and all bacteria were associated with squamous epithelial cells. Scant red 
blood cells were also documented on cytological examination of the voided sample. A 
comparison of urinalysis results for Cat B is shown in Table 4.7 and the morphology of colonies 
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cultured can be seen in Figure 4.3. A growth of approximately 13000 cfu/mL was documented 
and the predominate colonies cultured were suspected to be coliform in nature. A repeat urine 
culture of a voided sample 1-month post-inclusion was culture negative.  
 
Table 4.7: Comparison of discordant urinalyses results from Cat B. 
Parameter / Method of 
collection 
Cystocentesis sample Voided sample 
USG  > 1.050 > 1.050 
pH (pH meter) 6.2 6.9 
UPC 0.42 0.38 
Dipstick analysis 
Glucose - ++ 
Sediment examination 
White blood cells Scant - 
Red blood cells - - 
Bacteria + Scant 
Fat droplets ++++ +++ 
Cytology examination 
White blood cells - - 
Red blood cells - Scant 
Bacteria - ++ 
Urine culture 
Quantity Negative Moderate  
Purity N/A Mixed 
Species / Morphology N/A Predominately larger grey 




Figure 4.3: Blood agar plate from the voided urine sample of Cat B. 
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‘Cat C’ was female neutered and weighed 3.6kg. An enteropathy and clinical signs of lower 
respiratory tract disease were documented at presentation. Urine samples were collected 
1512 hours apart. The cystocentesis sample was collected first at the assessment visit and was 
culture negative. The voided sample was not obtained until Cat C re-presented to the Small 
Animal Teaching Hospital for RAI treatment. Clinical signs at the time of re-presentation 
included: occasional wheezing, nausea and inappetence. Voided urine remained in the litter 
tray for approximately 1-hour prior to collection and analysis. Pyuria and bacteriuria were 
documented on sediment examination of the voided sample only. Cytological evidence of 
inflammation and infection were also evident on the voided sample only. A monomorphic 
population of bacilli were reported with documentation of intra-cellular bacteria suggestive of 
genuine infection. Culture on blood agar plate documented a profuse, pure growth of a 
bacteria suspect to be coliform in nature as shown in Figure 4.4. A two-week course of 
clavulanate-potentiated amoxicillin was prescribed by the referring veterinary surgeon. Two 
subsequent urine cultures, one voided sample and one cystocentesis sample, each 
documented significant growth of E. coli. The isolates AST profile documented susceptibility to 
amoxicillin, clavulanate-potentiated amoxicillin, cephalexin, pradofloxacin, marbofloxacin, 
cefovecin and trimethoprim/sulphonamide and resistance to clindamycin. No clinical signs of 
lower urinary tract disease have been reported in Cat C. Radioactive iodine therapy has 
currently been withheld from Cat C and monitoring of urine culture status and renal 
parameters has been advised.  
 
 
Figure 4.4: Blood agar plate from the voided urine sample of Cat C. 
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4.1.3 Urinary Tract Infections 
4.1.3.1 Cystocentesis Samples  
As outlined in Table 4.5, no cats were diagnosed with a clinical UTI based on culture results of 
cystocentesis samples at the time of inclusion into the study. 
4.1.3.2 Voided Samples 
Three cats were diagnosed with a clinical UTI based upon positive cultures obtained from 
voided samples. Corresponding cystocentesis or SUB device samples were culture negative in 
all cases at the time of inclusion.  
All cats were domestic shorthair cats aged between 6 and 17 years. Two were female and one 
was male, all were neutered. Two voided samples were collected in the hospital 12 and 72 
hours post SUB device and cystocentesis samples respectively and one was collected by an 
owner at home and posted to Diagnostic Laboratory 96 hours post discharge. Two cats were 
presented for routine flushing of SUB devices whilst the third was presented for treatment of 
aspiration pneumonia.  
‘Cat D’ presented for routine flushing of bilateral SUB devices that had been placed 2 months 
prior. Urine culture from a cystocentesis sample at the time of placement was negative. No 
clinical signs of lower urinary tract disease had been documented prior to presentation. Urine 
cultures from samples obtained from both SUB devices were negative at presentation. No 
sediment examination of the SUB device urine was performed but cytological evidence of 
haematuria and inflammation were documented as shown in Figure 4.5. Two days post 
discharge, Cat D represented to the Small Animal Teaching Hospital with clinical signs of 
pollakiuria, lethargy and inappetence. A voided urine sample was obtained at the 
representation. Bacteriuria was documented on both sediment examination and cytological 
examination of the voided sample. A monomorphic population of bacilli were documented 
with intra-cellular bacteria observed as shown in Figure 4.6. Urine culture documented a 
profuse growth of E. coli demonstrating resistance to ampicillin and cefalexin but susceptible 
to the all other antimicrobials tested against. Cat D was prescribed clavulanate-potentiated 
amoxicillin at a dose rate of 15mg/kg TID for 4 weeks.  




Figure 4.5: Neutrophilic inflammation and haematuria documented on cytological examination of urine obtained 
from the SUB device of Cat D. 
Image magnification x1000. 
SUB – Subcutaneous ureteral bypass system.  
Repeat culture of urine samples obtained from both SUB devices 1-month later were negative. 
No clinical signs of lower urinary tract disease were reported after beginning antimicrobial 
therapy. Cytological evaluation of urine obtained from both SUB devices at this time 
documented marked neutrophilic inflammation with rare extracellular bacilli noted. A further 
4 weeks of clavulanate-potentiated amoxicillin was prescribed at the same dose rate.  
A further repeat urine culture 1-month later was negative from urine obtained from the right 
SUB device. Culture of urine obtained from the left SUB device documented growth of E. coli 
with the same AST profile as the isolate cultured 8 weeks prior. Ultrasound examination of the 
left SUB device documented kinking of the cystostomy tube within subcutaneous tissues. 
Patency of the left ureter was confirmed by contrast radiography and the left SUB device was 
subsequently removed. The SUB device, nephrostomy tube and cystostomy tube were 
cultured and each documented a profuse E. coli growth with the same AST profile. Cat D was 
prescribed clavulanate-potentiated amoxicillin at an increased dose rate of 25mg/kg TID for 7 
days with a view to re-culture urine after this course.  




Figure 4.6: Septic neutrophilic inflammation and haematuria documented on cytological examination of voided 
urine obtained from Cat D. 
Image magnification x1000. 
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‘Cat E’, had demonstrated signs of periuria and haematuria 3 weeks prior to presentation and 
had recently been treated for pyelonephritis caused by E. coli with marbofloxacin. At 
presentation the SUB device sample was culture negative. A voided sample was collected at 
home and posted to the Diagnostic Laboratory 96 hours post discharge. It was unknown how 
long the sample remained in the litter tray prior to collection. A comparison of urinalysis 
results obtained by each method of collection for Cat E are shown in Table 4.8. The blood agar 
plate is shown in Figure 4.7, colonies were non-haemolytic and catalase negative. Gram 
staining, aesculin testing and Lancefield Group testing were not performed and so either an 
Enterococcus spp. or Streptococcus spp. were suspected.  
Table 4.8: Comparison of discordant urinalyses results from Cat E. 
Parameter / Method of 
collection 
SUB device sample Voided sample 
Colour Red Pink 
USG  1.005 1.019 
pH (pH meter) 6.6 5.8 
UPC 10.40 1.03 
Dipstick analysis 
Blood +++ +++ 
Sediment examination 
White blood cells Scant Scant 
Red blood cells ++++ + 
Bacteria - ++ 
Struvite crystals - Scant 
Cytology examination 
White blood cells Scant - 
Red blood cells + - 
Bacteria - ++++ 
Urine culture 
Quantity No growth Profuse 
Purity N/A Mixed 
Species / Morphology N/A Predominate growth of non-
haemolytic small grey 
colonies. Scant growth of 
larger cream/yellow colonies.  
 




Figure 4.7: Blood agar plate from the voided urine sample of Cat E. 
A follow-up urine culture obtained from the SUB device of Cat E 8 months post-inclusion 
documented a polymicrobial infection with Streptococcus spp. (Lancefield group G) and two 
morphologically different E. coli. The E. coli isolates had the same AST profiles and were 
susceptible to all antimicrobials tested against. The Streptococcus isolate demonstrated 
resistance to marbofloxacin confirmed by Kirby-Bauer disc diffusion testing. Cat E is currently 
being treated with marbofloxacin (2mg/kg PO, SID) and clavulanate-potentiated amoxicillin 
(20mg/kg PO, TID) with a 3-week course of both antimicrobials prescribed. 
The cat referred for treatment of aspiration pneumonia, hereafter referred to as ‘Cat F’, had 
recently displayed dysuria and had a prior history of haematuria. Co-morbidities identified at 
presentation included: CKD (IRIS Stage II proteinuric [treating], non-hypertensive), chronic 
pancreatitis, degenerative joint disease and unilateral laryngeal paralysis. Paired urine samples 
in this case were collected 12 hours apart with the cystocentesis sample being collected first. 
Voided urine remained in the litter tray for approximately 2.5 hours prior to collection and 
analysis. Intravenous fluid therapy was being administered at the time of sample collection. 
Free catch urinalysis results documented a urine specific gravity of 1.017, urine pH of 6.0 and 
UPC of 0.23. No notable findings on dipstick analysis, sediment examination or cytological 
examination were reported. Cystocentesis urinalysis results were similar. The cultured 
organism from the voided sample was suspect to be a Proteus spp. due to the swarming 
documented on the blood agar plate. The urine culture from the cystocentesis sample was 
negative. The positive culture from the voided sample was suspected to represent 
contamination.  
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4.2 PROTEOMIC ANALYSIS 
4.2.1 Study Population  
Urine samples from 22 cats were analysed in two runs for this study. This included 20 paired 
samples (voided and cystocentesis) and 2 unpaired samples. Four cultured bacteria were also 
analysed.  
4.2.1.1 Urine Sediments 
4.2.1.1.a First Run 
Samples from 5 cats presenting with lower urinary tract signs or positive urine culture were 
analysed. Table 4.9 shows the breakdown of samples analysed for the first run based upon 
presence of lower urinary tract clinical signs and urine culture status. One paired sample 
analysed produced discordant culture results. Four cats had  clinical signs consistent with 
lower urinary tract disease at the time of inclusion. Three cats had a positive urine culture 
although one case was suspected to represent contamination.  
Median age at the time of enrolment was 11 years (range, 2-18 years). Of the 5 cats, 3 were 
female and 2 were male. All cats were neutered. Three cats were domestic shorthair cats and 2 
were domestic longhair cats. 
Table 4.9: Nature of clinical signs and culture status for cats analysed in the first run of proteomic analysis. 
LUT – Lower urinary tract, (C) – Cystocentesis sample, (FC) – Free catch sample. 
* A Proteus spp. was cultured from this samples and was suspected to represent contamination. 
# Denotes cultured bacteria were available for proteomic analysis. 
Presence of LUT signs / 
Culture status 
Culture positive Culture negative 
Current LUT signs 1 unpaired sample# (C) 
Half of a paired sample (FC)*                     
2 paired samples 
Half of a paired sample (C) 
No LUT signs 
 




4.2.1.1.b Second Run 
Samples from 17 cats were analysed in the second run. This included 14 cats that had no prior 
history of lower urinary tract clinical signs and 3 cats presenting with lower urinary tract 
clinical signs. A voided sample from a cat with no lower urinary tract clinical signs was positive 
on urine culture, all other urine cultures from cats without lower urinary tract clinical signs 
were negative. Of the three cats presenting with lower urinary tract clinical signs, bacterial 
cystitis was documented in one case. Table 4.10 shows the breakdown of samples analysed in 
the second run. 
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Median age at the time of enrolment was 12 years (range, 5-18 years). Of the 17 cats, 11 were 
female and 6 were male. All cats were neutered. Sixteen cats were domestic shorthair cats and 
1 was a domestic medium hair cat. 
Table 4.10: Nature of clinical signs and culture status for cats analysed in the second run of proteomic analysis. 
LUT – Lower urinary tract, (C) – Cystocentesis sample, (FC) Free catch sample, (SUB) Subcutaneous ureteral bypass 
system sample. 
# Denotes cultured bacteria were available for proteomic analysis.  
Presence of LUT signs / 
Culture status 
Culture positive Culture negative 
Current LUT signs 1 unpaired sample# (FC) 2 paired samples 
No LUT signs 
 
Half of a paired sample# (FC)                     13 paired samples 
Half of a paired sample (C) 
4.2.1.2 Bacteria 
4.2.1.2.a First Run  
Two bacteria were available for analysis (marked by # in Table 4.9). One E. coli isolate obtained 
from the unpaired cystocentesis sample from a cat with UTI and one suspected Enterococcus 
sp. obtained from the voided sample of the cat with subclinical bacteriuria (Cat A).  
4.2.1.2.b Second Run  
Two bacteria were available for analysis (marked by # in Table 4.10). Both were E. coli isolates 
obtained from voided samples. One cat had confirmed UTI (Cat D), the other is suspected to 
have subclinical bacteriuria (Cat C).  
4.2.2 Urine Sediment - Uniprot Felis catus Searches 
4.2.2.1 First Run  
Described below (Sections 4.2.2.1.a - 4.2.2.1.c) are the number and nature of feline proteins 
identified for each study group in the first run of analyses. Any differences in protein 
expression according to method of collection are also highlighted. A summary table is provided 
in section 4.2.2.1.d. 
4.2.2.1.a Culture Negative Cats with Lower Urinary Tract Clinical Signs 
Three paired samples were compared from cats that presented with lower urinary tract clinical 
signs. 
One hundred and nineteen and one hundred and twenty-five feline proteins with unique 
accession numbers were identified in the cystocentesis and voided samples respectively. 
Twenty-seven and twenty-eight proteins identified in the cystocentesis and voided samples 
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respectively were uncharacterised by the software and removed from further analysis. 
Seventy-seven proteins were identified in both the cystocentesis and voided samples of all 
three pairs.  
Uromodulin was the most abundant protein in all voided samples and was on average 9.5x 
more abundant than albumin. Carboxylicesterases and haemoglobin-derived proteins were 
frequently identified in greater abundance than albumin. Haematuria was reported as a 
historical clinical sign in 2 cats and as a current clinical sign in the third.  
Of note, fibronectin was identified in all cystocentesis and voided samples in cats presenting 
with lower urinary tract disease with a mean abundance of 0.007 and 0.032 respectively 
relative to albumin. A full description of proteins identified in this group can be found in 
Supplementary Table S1. 
4.2.2.1.b Culture Positive Cats with Lower Urinary Tract Clinical Signs  
One cystocentesis sample from a cat with confirmed bacterial cystitis was analysed. Five 
hundred and fifty-six feline proteins with unique accession numbers were identified, eighty-
two of which were uncharacterised and excluded from further analysis.  
Actin was the most abundant protein identified in this sample followed by myeloperoxidase 
and uromodulin at abundances of 4.05, 2.93 and 2.5 respectively relative to albumin.  
Up to 9 histone proteins were differentially identified in the cat with a positive urine culture 
compared to culture negative cats. An elastase expressed by neutrophils was also identified in 
this sample at an abundance of 2.2 relative to albumin. This protein was not identified in 
samples obtained from culture negative cats. A full description of proteins identified in this 
group can be found in Supplementary Table S2. 
4.2.2.1.c Culture Positive Cats with No Lower Urinary Tract Clinical Signs 
One paired sample from Cat A in section 4.1.2 with subclinical bacteriuria was analysed. The 
cystocentesis sample was collected 5-weeks after the voided sample. Positive urine cultures 
with growth of Enterococcus spp. were identified in both samples. 
Two hundred and twenty-five unique accession numbers were identified in the cystocentesis 
sample and three hundred and fifty-five were identified in the voided sample. One hundred 
and ninety-three feline proteins with unique accession numbers were common to both the 
cystocentesis and voided samples. 
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Haemoglobin derived proteins were the most abundant protein type in the voided sample with 
an abundance of 2.0 relative to albumin. These proteins were also present in the cystocentesis 
sample but at an abundance of 0.5 relative to albumin. Haematuria was documented in the 
urinalysis of both samples.  
The neutrophil-expressed elastase identified in the clinical UTI sample was also identified in 
both the voided and cystocentesis sample.  
One hundred and seventeen unique accession numbers were identified in this case of 
subclinical bacteriuria that were not identified in the clinical UTI sample. Thirty-five of these 
were uncharacterised by the identification software. The most abundant unique proteins 
identified were haemoglobin-derived proteins, actin and fragments of IgG lambda chain 
regions. A full description of proteins identified in this group can be found in Supplementary 
Table S3. 
4.2.2.1.d  Summary Table 
 
 Table 4.11: The number of feline proteins identified in each group of cats from the first run for cystocentesis 
samples, voided samples and common to both methods of collection. 
LUT – Lower urinary tract. 
  
4.2.2.2 Second Run 
 Described below (Sections 4.2.2.2.a - 4.2.2.2.e) are the number and nature of feline proteins 
identified for each study group in the second run of analyses. Any differences in protein 
expression according to method of collection are also highlighted. A summary table is provided 
in section 4.2.2.2.f. 
4.2.2.2.a Culture Negative Cats without Lower Urinary Tract Clinical Signs 
Thirteen paired samples from culture negative cats without lower urinary tract clinical signs 
were analysed. One hundred and five and one hundred and fifteen unique accession numbers 
were identified in all thirteen cystocentesis and voided samples respectively. Eighty-two and 
 Cystocentesis 
samples 
Voided samples Common to both 
Culture negative 
with LUT signs (n=3) 
119 125 77 
Culture positive 
with LUT signs (n=1) 
556 N/A N/A 
Culture positive 
without LUT signs 
(n=1) 
225 355 193 
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eighty-four proteins identified in the cystocentesis and voided samples respectively were 
uncharacterised by the software used and removed from further analysis. Forty-nine proteins 
were identified in both the cystocentesis and the voided sample.  
Uromodulin was the most abundant protein in voided samples and carboxylicesterases were 
more abundant in cystocentesis samples. Haemoglobin-derived proteins were identified in all 
samples despite no cat having any history of haematuria reported.  
Fibronectin was identified in all samples with a mean abundance of 0.012 relative to albumin 
for both cystocentesis and voided samples. A full description of proteins identified in this 
group can be found in Supplementary Table S4. 
4.2.2.2.b Culture Negative Cats with Lower Urinary Tract Clinical Signs 
Two paired samples from cats with lower urinary tract clinical signs but negative urine cultures 
were analysed. One hundred and twenty-one unique accession numbers were identified both 
cystocentesis samples and one hundred and forty-three were identified in both voided 
samples. Ninety-six proteins were common to all samples in this group. The most abundant 
proteins identified were a haemoglobin-derived protein and uromodulin in cystocentesis and 
voided samples respectively.  
Sixty-six protein accession numbers identified in  cats with lower urinary tract clinical signs 
were also identified the culture negative cats without lower urinary tract clinical signs. After 
visual inspection of remaining accession numbers and protein descriptions, 2 unique proteins 
were identified in culture negative cats with lower urinary tract clinical signs that were not 
identified in culture negative cats without lower urinary tract clinical signs. These were actin 
and an ATP synthase beta subunit.  
Fibronectin was identified in all samples with a mean abundance of 0.005 and 0.02 relative to 
albumin for cystocentesis and voided samples respectively. A full description of proteins 
identified in this group can be found in Supplementary Table S5. 
4.2.2.2.c Culture Positive Cats with Lower Urinary Tract Clinical Signs 
One voided urine sample from Cat D in section 4.1.3 with an E. coli UTI was analysed. Four 
hundred and thirty-nine unique accession numbers were identified in this sample. The most 
abundant protein identified was albumin followed by an uncharacterised protein, uromodulin 
and haemoglobin-derived proteins.  
Two hundred and sixty-two of the accession numbers identified in this sample were also 
identified in the UTI sample described in 4.2.2.1.b. Of note, these included: actin, IgG chain 
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fragments, haptoglobin, myeloperoxidase, fibrinogen, transferrin, RBP and neutrophil-
expressed elastase. A full description of proteins identified in this group can be found in 
Supplementary Table S6. 
4.2.2.2.d Culture Positive Cats without Lower Urinary Tract Clinical Signs 
One voided urine sample from Cat C in section 4.1.2.2 with suspected subclinical bacteriuria 
due to E. coli was analysed. Four hundred and twenty-six proteins were identified in this 
sample, one hundred and sixty-nine of which were also identified in both samples from the 
culture positive cats without lower urinary tract clinical signs described in section 4.2.2.1.c.  
One hundred and eleven of the accession numbers identified in all suspected cases of 
subclinical bacteriuria were also identified in at least of one the culture negative cats without 
lower urinary tract clinical described in section 4.2.2.2.a. 
Fifty-seven accession numbers were identified in suspected cases of subclinical bacteriuria that 
were not identified in culture negative cats with no lower urinary tract clinical signs. Two of 
the fifty-seven accession numbers were identified in at least one of the , culture negative cats 
with lower urinary tract signs described in sections 4.2.2.1.a and 4.2.2.2.b respectively 
Fifty-five accession numbers identified in cases of subclinical bacteriuria were also identified in 
cases of UTI. Two unique accession numbers were solely identified in all cases of subclinical 
bacteriuria, both proteins were uncharacterised by the software used but had molecular 
weights of 43.4 kDa and 59.6 kDa. Accession numbers, descriptions, number of amino acids 
and the molecular weight of both proteins are reported in Table 4.12. The Basic Local 
Alignment Search Tool (BLAST) of the Uniprot database was used to search for regions of 
similarity between sequences of the uncharacterised proteins identified in this study and other 
proteins within the database. For the accession number A0A2I2V2Y7, 61% of the sequence was 
identical to human complement factor H (Uniprot, 2019). A full description of proteins 
identified in this group can be found in Supplementary Table S7. 
Table 4.12: Description of the two unique proteins identified in only cases of suspected subclinical bacteriuria. 
# AAs – Number of amino acids, MW – Molecular weight, kDa – Kilodalton. 
Accession 
Number 
Description # AAs MW 
(kDa) 
A0A2I2V2Y7 Uncharacterized protein OS=Felis catus OX=9685 PE=4 
SV=2 - [A0A2I2V2Y7_FELCA] 
380 43.4 
M3VUG0 Uncharacterized protein OS=Felis catus OX=9685 
GN=LOC105259896 PE=3 SV=3 - [M3VUG0_FELCA]  
560 59.6 
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4.2.2.2.e Deionised Water Controls 
Forty-two accession numbers were identified in both control samples. Uromodulin and two 
haemoglobin subunit proteins were identified at a greater abundance than albumin. Ten of the 
forty-two accession numbers corresponded to keratin proteins. Eight of the accession numbers 
were uncharacterised by the identification software.  
Analysis of control samples was repeated. Prior to the repeat analysis samples were frozen at  
-20°C for 5 weeks. Ten accession numbers were identified in both control samples in the 
repeat analysis. Two of these accession numbers were not identified in the first analysis and 
these accession numbers both corresponded to uncharacterised proteins. Seven of the ten 
accession numbers identified in both control samples corresponded to keratin proteins, two 
corresponded to uncharacterised proteins and one corresponded to albumin.  
A further 8 accession numbers were identified in the cystocentesis control sample that were 
not identified in the voided control sample. These included: uromodulin, haemoglobin subunit 
proteins, proteins involved in desmosome formations and uncharacterised proteins.  
4.2.2.2.f Summary Table 
 
 Table 4.13: The number of feline proteins identified in each group of cats from the second run for cystocentesis 
samples, voided samples and common to both methods of collection. 
LUT – Lower urinary tract. 
 
4.2.3 Urine sediment - SwissProt Eubacteria Searches 
4.2.3.1 First Run 
Described below are the number and nature of bacterial proteins identified for each study 
group in the first run of analyses. Any differences in protein expression according to method of 
collection are also highlighted. A summary table is provided in section 4.2.3.1.d. 
 Cystocentesis 
samples 
Voided samples Common to both 
Culture negative 
without LUT signs 
(n=13) 
105 115 49 
Culture negative 
with LUT signs(n=2) 
121 143 96 
Culture positive with 
LUT signs (n=1) 
N/A 439 N/A 
Culture positive 
without LUT signs 
(n=1) 
N/A 426 N/A 
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4.2.3.1.a Culture Negative Cats with Lower Urinary Tract Clinical Signs 
Three paired samples were analysed. A mean of 310 bacterial proteins were identified in each 
individual sample. On average, 71 more bacterial proteins were identified in cystocentesis 
samples than in voided samples.  
One hundred and seventeen unique accession numbers were identified in all samples. One 
hundred (85%) of these proteins were identified as Pseudomonas spp. proteins. These 
included: membrane proteins, elongation factors, ATP synthase subunits, ATP binding proteins, 
ribosomal proteins, polymyxin-resistance proteins, transcription factors, DNA binding proteins 
and an RNA polymerase. 
Other genera identified in all samples included: Enterobacter, Escherichia, Francisella, Hahella, 
Marinobacter, Pseudoalteromonas, Psychrobacter, Serratia, Shewanella and Teredinibacter. All 
genera identified in all samples belonged to the Proteobacteria phylum. A full description of 
proteins identified in this group can be found in Supplementary Table S8. 
4.2.3.1.b Culture Positive Cats with Lower Urinary Tract Clinical Signs  
One cystocentesis sample from a cat with confirmed E. coli bacterial cystitis was analysed. 
Sixty-six bacterial proteins were identified in this sample, thirteen of which were identified as E. 
coli proteins. These included: membrane proteins, elongation factors, ATP synthase subunits 
and ribosomal proteins. 
Thirty proteins identified in this sample belonged to the Pseudomonas genus. These included: 
membrane proteins, elongation factors, ATP synthase subunits, ribosomal proteins, DNA 
binding proteins and an RNA polymerase.  
Proteins belonging to Yersinia, Serratia, Shigella, Xanthobacter, Streptococcus, Clostridium and 
Azotobacter genera were also identified in this sample. A full description of proteins identified 
in this group can be found in Supplementary Table S9. 
4.2.3.1.c Culture Positive Cats without Lower Urinary Tract Clinical Signs 
One paired sample from Cat A in section 4.1.2 with Enterococcus spp. subclinical bacteriuria 
was analysed. Three hundred and thirty bacterial proteins were identified in the cystocentesis 
sample and one hundred and forty-two in the voided sample. One hundred and thirty-seven 
proteins were identified in both samples.  
Of the proteins identified in both samples, 83 belonged to the Pseudomonas genus. 
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Sixty-two proteins identified in both samples from this cat were also identified in all cases of  
culture negative with lower urinary tract clinical signs cats described in section 4.2.3.1.a, fifty-
seven of which belonged to the Pseudomonas genus.  
Three Enterococcus spp.  bacterial proteins were identified in the voided sample of this cat. No 
Enterococcus spp. proteins were identified in the cystocentesis sample. A full description of 
proteins identified in this group can be found in Supplementary Table S10. 
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4.2.3.1.d Summary Table 
Table 4.14: The number of bacterial proteins identified in each group of cats from the first run for cystocentesis 
samples, voided samples and common to both methods of collection. 
LUT – Lower urinary tract. 
 Cystocentesis 
samples 
Voided samples Common to both 
Culture negative 
with LUT signs (n=3) 
188 126 117 
Culture positive 
with LUT signs (n=1) 
66 N/A N/A 
Culture positive 
without LUT signs 
(n=1) 
330 142 137 
 
4.2.3.2 Second Run 
Described below are the number and nature of bacterial proteins identified for each study 
group in the second run of analyses. Any differences in protein expression according to 
method of collection are also highlighted. A summary table is provided in section 4.2.3.2.f. 
4.2.3.2.a Culture Negative Cats without Lower Urinary Tract Clinical Signs 
Of 13 paired urine samples analysed up to 51 bacterial proteins were identified in 5 
cystocentesis and up to 78 proteins were identified in 7 voided samples. In 4 cases, bacterial 
proteins were identified in both the voided and cystocentesis samples. In 3 cases, bacterial 
proteins were identified in the voided sample only and in 1 case bacterial proteins were 
identified in the cystocentesis sample only.  
Fifteen bacterial proteins were identified in all 5 of the bacterial protein-positive cystocentesis 
samples. Bacterial proteins identified largely belonged to the Enterobacteriaceae family with 
Serratia, Salmonella and Klebsiella being the most commonly identified genera.  
No protein identified was common to the 7 bacterial protein-positive free catch samples. A 
protein identified as an elongation factor of Serratia proteamaculans was identified in 6 of 7 
samples. Nine proteins identified were common to five voided samples. Each protein identified 
common to 5 or more samples was of a unique genus. Proteins identified most commonly 
belonged to the Enterobacteriaceae family. A full description of proteins identified in this 
group can be found in Supplementary Table S11.  
4.2.3.2.b Culture Negative Cats with Lower Urinary Tract Clinical Signs 
Two paired samples were analysed from cats currently displaying clinical signs of lower urinary 
tract disease but with negative urine cultures.  
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In one paired sample, 0 and 9 bacterial proteins were identified in the cystocentesis and 
voided samples respectively. Two proteins were identified as E. coli proteins. Other genera 
identified included: Erwinia, Magnetospirillum, Rhodobacter, Rhodopseudomonas, Serratia, 
Xanthobacter and Yersinia, all of which belong to the Proteobacteria phylum.  
In the second paired sample analysed, 33 and 6 bacterial proteins were identified in the 
cystocentesis and voided samples respectively. Six Serratia spp. and five E. coli proteins were 
identified in the cystocentesis sample. Of note, a protein identified as a Mycobacterium bovis 
protein was identified in the cystocentesis sample.  
Of the 6 proteins identified in the voided samples, 5 were also identified in the cystocentesis 
sample. A Rhodobacter spp. protein was identified in the voided sample only. A full description 
of proteins identified in this group can be found in Supplementary Table S12. 
4.2.3.2.c Culture Positive Cats with Lower Urinary Tract Clinical Signs 
One voided urine sample from Cat D in section 4.1.3 with an E. coli UTI was analysed. Four 
hundred and seventy-three bacterial proteins were identified in this sample. Of which 380 
(80%) were identified as E. coli proteins.  
Citrobacter, Enterobacter, Klebsiella and Salmonella proteins were frequently identified. Only 
two proteins were identified as Pseudomonas spp. proteins. A full description of proteins 
identified in this group can be found in Supplementary Table S13. 
4.2.3.2.d Culture Positive Cats without Lower Urinary Tract Clinical Signs 
One voided urine sample from Cat C in section 4.1.2.2 with suspected subclinical bacteriuria 
due to E. coli was analysed. Four hundred and eighty-seven bacterial proteins were identified 
in this sample. Of which 395 (81%) were identified as E. coli proteins. Two proteins were 
identified as Pseudomonas spp. proteins. A full description of proteins identified in this group 
can be found in Supplementary Table S14. 
4.2.3.2.e Deionised Water Controls  
One hundred and twelve bacterial proteins were identified in both deionised water control 
samples. A further 88 bacterial proteins were identified in the sample prepared as a 
cystocentesis sample and a further 9 bacterial proteins were identified in the sample prepared 
as a voided sample. Bacterial proteins identified largely belonged to the Enterobacteriaceae 
family with Enterobacter, Escherichia, Serratia and Yersinia being commonly identified genera. 
Sixteen proteins belonging to the genus Pseudomonas were also identified.  
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Analysis of control samples was repeated. Prior to the repeat analysis samples were frozen at -
20°C for 5-weeks. Three and one bacterial proteins were identified the cystocentesis control 
and voided control samples respectively. A carbapenem-hydrolysing beta-lactamase from a 
Klebsiella spp. was identified in both samples. A membrane protein from an Escherichia spp. 
and a nitrile hydratase from a Rhodococcus spp. were identified in only the cystocentesis 
control sample.  
4.2.3.2.f Summary Table 
Table 4.15: The number of bacterial proteins identified in each group of cats from the second run for cystocentesis 
samples, voided samples and common to both methods of collection. 
LUT – Lower urinary tract.  
 Cystocentesis 
samples 
Voided samples Common to both 
Culture negative 
without LUT signs 
(n=13) 
Up to 51 in 7 
samples 












with LUT signs (n=1) 
N/A 473 N/A 
Culture positive 
without LUT signs 
(n=1) 
N/A 487 N/A 
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4.2.4 Bacterial Analysis 
4.2.4.1 First Run  
Eight hundred and sixty-four bacterial proteins were identified from the E. coli isolated from 
the cystocentesis sample of the cat with bacterial cystitis. Of these, 721 (83%) were identified 
as E. coli proteins. Eleven of the proteins identified from the E. coli isolate were also identified 
in the corresponding urine sediment. These included: membrane proteins, an elongation 
factor, 30S and 50S ribosomal proteins and pyruvate dehydrogenase complex proteins.   
Two hundred and fifty-three bacterial proteins were identified from the Enterococcus spp. 
isolated from Cat A. Of these, 139 (55%) were identified as Enterococcus faecalis proteins, 85 
(34%) were identified as E. coli proteins. Twelve other genera of bacteria were also identified.  
The 3 Enterococcus faecalis proteins identified in the corresponding urine sediment were 
identified in the bacterial analysis. These were an elongation factor, an enolase and a 
triosephosphate isomerase.  
4.2.4.2 Second Run 
Four hundred and eighty-one bacterial proteins were identified from the E. coli isolated from 
the voided sample of Cat D. Of these, 342 (71%) were identified as E. coli proteins. One 
hundred and ninety-eight proteins identified from the E. coli isolate were also identified in the 
corresponding urine sediment. 
Eight proteins were identified from the E. coli isolated from the voided sample of the Cat C 
with subclinical bacteriuria. Of these, 2 (25%) were identified as E. coli proteins. Other genera 
identified included: Enterobacter, Erwinia, Klebsiella, Photorhabdus, Serratia and Sodalis. One 
of the E. coli proteins identified was also identified in the corresponding urine sediment.  
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4.3 THE EFFECT OF NON-ABSORBENT HYDROPHOBIC SAND LITTER ON URINE PROTEIN-
TO-CREATININE MEASUREMENTS 
4.3.1 Experiment 1 – Pilot Investigation 
Thirty-five urine samples obtained by cystocentesis were used for the pilot investigation. Three 
millilitres of urine were placed into a Petri dish containing 20g of non-absorbent litter. After 24 
hours, no urine was available for recovery from any sample. All urine appeared to have 
absorbed into the litter or evaporated.  
4.3.2 Experiment 2 and 3 – 40 Samples  
4.3.2.1 Study Population 
Forty urine samples were obtained from thirty-nine cats over a six-month period. All urine 
samples were obtained by cystocentesis. Of the 40 urine samples obtained, 34 were obtained 
from the Small Animal Teaching Hospital and 6 were submitted to the Diagnostic Laboratory 
from external veterinary practices.  
Median age at the time of enrolment was 11 years (range, 1-18). Of the 39 cats, 21 (54%) were 
male and 18 (46%) were female. One female cat was entire and the sex status of one male was 
not recorded. All other cats were neutered. Of the 39 cats, 29 (74%) were domestic shorthair 
cats, 3 (8%) were domestic longhair cats, 2 (5%) were Persian and Bengal and 1 (3%) of each of 
the following breeds were included: British Blue, Maine Coon cross and Siamese.  
4.3.2.2 Volume of Samples 
From the 3mL placed into each Petri dish, a mean volume of 2.5mL (range, 1.0-2.9) were 
recovered after 24 hours.  
4.3.2.3 Sediment Examination 
Of the 40 samples analysed, 27 (67.5%) were classified as having an inactive sediment and 13 
(32.5%) were classified as having an active sediment.  
4.3.2.4 Urine Protein-to-Creatinine Ratios 
The median baseline UPC was 0.17 (range, 0.05-5.59). The median baseline urine protein and 
urine creatinine concentrations were 38.13mg/dL (range, 7.35-277.90) and 215.58mg/dL 
(range, 17.53-640.21) respectively. The median UPC at 24 hours was 0.16 (range, 0.05-5.22). 
The median urine protein and urine creatinine concentrations at 24 hours were 37.85mg/dL 
(range, 5.9-279.00) and 215.67mg/dL (range, 18.10-657.01) respectively.   
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Out of 40 samples, a decrease in UPC after 24 hours was observed in 29 (72.5%) cases. An 
increase in UPC was observed in 3 (7.5%) cases and no change in UPC was observed in 8 (20%) 
of cases. There was a statistically significant median decrease in UPC of 0.01 after urine was 
exposed to non-absorbent hydrophobic sand litter for 24 hours, p<0.0005.  
A decrease in urinary protein concentration after 24 hours was observed in 26 (65%) cases and 
an increase in concentration was observed in 14 (35%) cases. There was no statistically 
significant change in urinary protein concentration observed after urine was exposed to non-
absorbent hydrophobic sand litter for 24 hours, p=0.082. 
An increase in urinary creatinine concentration was observed in 34 (85%) cases and a decrease 
observed in 6 (15%) cases. A statistically significant median increase in urinary creatine 
concentration measurement of 5.76mg/dL was observed after urine was exposed to non-
absorbent hydrophobic sand litter for 24 hours, p<0.0005. 
The absolute mean difference in UPC observed over 24 hours was 0.04, equivalent to 8.89% 
absolute mean change. Absolute percentage changes observed in paired UPC samples ranged 
from 0% to 31.38%. Absolute mean percentage changes observed at 24 hours in urinary 
protein and creatinine concentrations were 6.86% and 7.25% respectively.  
There was a statistically significant, strong positive correlation between UPC measured at 
baseline and UPC measured after urine was exposed to non-absorbent hydrophobic sand litter 
for 24 hours, rs=0.988, p<0.0005. 
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Passing-Bablok regression analysis revealed minimal constant and proportional error. The 
regression equation of y= -0.0038 + 0.9606𝑥𝑥 with 95% confidence intervals (CI) for the 
intercept and slope of -0.0126 to 0.0040 and 0.9198 to 1.0046 respectively, suggests that UPC 
measurements at baseline or after 24-hour exposure to non-absorbent hydrophobic litter can 




Figure 4.8: Passing-Bablok regression analysis of UPC measured at baseline and after 24-hour exposure to non-
absorbent hydrophobic sand litter. n=40; UPC range 0.05-5.59; Spearman correlation coefficient 0.988, p<0.0005. 
Scatter chart with regression line and confidence bands for regression line shown. Regression line is solid.  
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A difference versus average Bland-Altman plot (Figure 4.9) demonstrated agreement between 
the UPCs obtained at baseline and after 24 hours exposure to non-absorbent hydrophobic 
sand litter for samples with UPC <2. The mean bias of the differences of paired UPC measures 
was -0.02075 and the 95% limits of agreement ranged from -0.1896 to 0.1481. The 95% CI for 
the calculated mean bias and 95% limits of agreement are outlined in Table 4.16. No real bias 
was evident as the 95% CI for the mean bias included 0 (Table 4.16), thereby demonstrating 
excellent agreement between the two measurements. Visual assessment of the plot suggested 
a possible negative proportional bias trend; however this is limited by the low numbers of 
samples with UPC >2. 
Two paired UPC measures fell outside of the 95% limits of agreement. These values had a 
larger difference in UPC observed at 24 hours of -0.37 and 0.35. Actual values of UPC  
decreased from 5.59 to 5.22 and increased from 2.38 to 2.73 equivalent to absolute % changes 
of 6.62% and 14.71% respectively. Both sediments were classified as active with haematuria 
and pyuria documented in one case and bacteriuria in the other. The IRIS category for 
proteinuria did not change in either case.  
 
 
Figure 4.9: Difference versus average Bland-Altman plot of UPC measures obtained at baseline and after 24 hours 
exposure to non-absorbent hydrophobic sand litter. N=40.  
Solid blue line represents the mean of the difference (bias) = -0.02075 
Blue dashed lines represent the 95% limits of agreement from -0.1896 to 0.1481 
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Table 4.16: Mean bias and 95% limits of agreement (LOA) for Bland-Altman analysis with 95% confidence 
intervals (CI) reported to two decimal places. 
Mean Bias (95% CI) Lower LOA (95% CI) Upper LOA (95% CI) 
-0.02 (-0.05 to 0.01) -0.19 (-0.24 to -0.14) 0.15 (0.10 to 0.19) 
 
Of the 40 samples, at baseline, 22 (55%) were classified as non-proteinuric, 8 (20%) were 
classified as borderline proteinuric and 10 (25%) were classified as proteinuric as defined by 
IRIS (outlined in Table 4.17). Two samples changed IRIS category at 24 hours. One from 
borderline proteinuric to non-proteinuric and one from proteinuric to borderline proteinuric. 
The number of samples recorded within each IRIS category at baseline and 24 hours is shown 
in Table 4.18.  
Table 4.17: Classification of feline proteinuria as defined by the International Renal Interest Society. 
UPC Measurement IRIS category of proteinuria 
<0.2 Non-proteinuric 
0.2 – 0.4 Borderline proteinuric 
>0.4 Proteinuric 
 
Table 4.18: Number of samples within each IRIS proteinuria category at baseline and at 24 hours. 
Discordant results are highlighted.  










22 0 0 
Borderline 
proteinuric 
1 7 0 
Proteinuric 
 
0 1 9 
 
IRIS categories for proteinuria were concordant in 38 (95%) cases. IRIS category changed by no 
more than one level for any discordant case. The kappa coefficient was κ=0.915, p<0.0005, 
corresponding to almost perfect agreement according to Landis and Koch (1977) between IRIS 
categories obtained at baseline and 24 hours. 
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4.4 THE EFFECT OF URINE SAMPLE COLLECTION TECHNIQUE ON COMMON URINALYSIS 
PARAMETERS 
4.4.1 Study Population  
Paired urinalyses results from 43 cats were used for this investigation.  The mean time delay 
between obtaining paired urine samples was 9.7 hours (range, 1-23 hours). The voided sample 
was obtained first in 35 cases and the cystocentesis sample in 8 cases. No samples obtained 
from SUB devices were used for this investigation. 
Median age at the time of enrolment was 12 years (range, 2-18). Of the 43 cats, 21 were male 
and 22 were female. All cats were neutered. Of the 43 cats, 32 (74%) were domestic shorthair 
cats, 4 (9%) were domestic longhair cats and 1 of each of the following breeds were included: 
domestic medium hair, Bengal, British shorthair, Burmese, Maine Coon, Persian and Persian-
cross. 
4.4.2 Urine Specific Gravity, pH and Urine Protein-to-Creatinine Ratios 
The difference between paired measures of all continuous variables were not normally 
distributed as assed by the Shapiro-Wilk test. The differences in parameters observed 
according to method of collection were not symmetrically distributed when assessed visually 
on a histogram for USG and pH. The differences observed were symmetrically distributed 
when assessed visually on a histogram for UPC. 
4.4.2.1 Urine Specific Gravity 
The median USG recorded for voided samples and cystocentesis samples was 1.035 (range, 
1.007 to >1.050) and 1.036 (range, 1.008 to >1.050) respectively. Out of 43 paired samples, a 
higher USG was observed in the voided sample in 18 (42%) cases. A higher USG was observed 
in the cystocentesis sample in 16 (37%) cases and no change in USG was observed in 9 (21%) 
cases. There was no statistically significant median change in USG when free catch techniques 
were used to obtain urine, p=0.864.  
In 4 cases, a USG of ≥1.035 was observed in cystocentesis samples and a USG of <1.035 
observed in corresponding voided sample. In two cases, a USG of ≥1.035 was observed in the 
voided samples and a USG of <1.035 observed in corresponding cystocentesis samples. 
  




The median pH recorded for voided samples and cystocentesis samples was 6.7 (range, 5.8-8.5) 
and 6.4 (range, 5.1-8.1) respectively.  Out of 43 paired samples, a higher pH was observed in 
the voided sample in 22 (51%) cases. A higher pH was observed in the cystocentesis sample in 
12 (28%) cases and no change in pH was observed in 9 (21%) cases. There was no statistically 
significant difference in urine pH when free catch techniques were used to obtain urine, 
p=0.123. 
4.4.2.3 Urine Protein-to-Creatinine Ratios 
The median UPC recorded for voided samples and cystocentesis samples was 0.24 (range, 0.06 
to 0.99) and 0.27 (range, 0.09 to 0.79) respectively. Out of 43 paired samples, a higher UPC 
was observed in the voided sample in 8 (18.6%) cases. A higher UPC was observed in the 
cystocentesis sample in 30 (70%) cases and no change in UPC was observed in 5 (12%) cases. 
There was a statistically significant median decrease in UPC of 0.04 when free catch techniques 
were used to obtain urine, p<0.0005. 
There was a statistically significant, strong positive correlation between UPCs determined from 
voided urine samples and from cystocentesis samples, rs=0.937, p<0.0005. 
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For all samples, Passing-Bablok regression analysis revealed minimal constant and proportional 
error. The regression equation of y= -0.0019 + 0.8596x with 95% CI for the intercept and slope 
of -0.04 to 0.0257 and 0.7619 to 1.00 respectively. A scatter plot with the regression line and 
95% CI are shown in Figure 4.10. 
 
 
Figure 4.10: Passing-Bablok regression analysis of UPCs determined from voided urine samples and from 
cystocentesis samples. n=43; UPC range 0.06-0.99; Spearman correlation coefficient 0.937, p<0.0005. Scatter 
chart with regression line and confidence bands for regression line shown. Regression line is solid.  
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A difference versus average Bland-Altman plot (Figure 4.11) was used to judge acceptability 
between the UPCs determined from voided samples and cystocentesis samples. For all 
samples, the mean bias of paired UPC measures was -0.05 and the 95% limits of agreement 
ranged from -0.24 to 0.14. The 95% confidence intervals for the calculated mean bias and 95% 
limits of agreement are outlined in Table 4.19. Three paired UPC measures fell outside of the 
95% limits of agreement. These values had a larger difference in UPC observed between 
methods of collection of -0.36, -0.34 and 0.32. These differences were equivalent to absolute % 
changes of 47.76%, 48.65% and 43.04% respectively. All urine samples that fell outside the 95% 
limits of agreement had active sediments and a mean UPC of >0.55. 
 
Table 4.19: Mean bias and 95% limits of agreement (LOA) for Bland-Altman analysis with 95% confidence 




Mean Bias (95% CI) Lower LOA (95% CI) Upper LOA (95% CI) 
All Samples (43) -0.05 (-0.08 to -0.02) -0.24 (-0.29 to -0.19) 0.14 (0.09 to 0.19) 
Active (20) -0.06 (-0.12 to 0.01) -0.32 (-0.43 to -0.21) 0.21 (0.10 to 0.32) 
Inactive (23) -0.04 (-0.06 to -0.02) -0.13 (-0.16 to -0.09) 0.05 (0.02 to 0.09) 




Figure 4.11: Difference versus average Bland-Altman plot of UPC measures obtained from free catch urine and 
cystocentesis samples. n=43 
Solid blue line represents the mean of the difference (bias) = -0.05 
Blue dashed lines represent the 95% limits of agreement from -0.24 to 0.14. 
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For samples with active sediments, the Passing-Bablok regression equation was y= -0.0136 + 
0.8800x with 95% CI for the intercept and slope of -0.0136 to 0.0944 and 0.6429 to 1.1176 
respectively. Despite still including 0, the 95% CI for the slope in the subset of sample with 
active sediments were wider than that for the subset of samples with inactive sediments.  A 
scatter plot with the regression line and 95% CI are shown in Figure 4.12. 
 
 
Figure 4.12: Passing-Bablok regression analysis of UPCs determined from voided urine samples and from 
cystocentesis samples with active sediments. n=20; UPC range 0.09-0.99; Spearman correlation coefficient 0.875, 
p<0.0005. Scatter chart with regression line and confidence bands for regression line shown. Regression line is 
solid.  
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Visual inspection of the Bland-Altman plot for urine samples with active sediments revealed 
poor agreement between methods of collection for UPCs. For samples with active sediments, 
the 95% limits of agreement calculated from the Bland-Altman plot span 0.53, which would be 
unacceptable for UPC measurements. A minimum of 40 samples with active sediments would 
however be needed to draw meaningful conclusions from this subset. 
 
Figure 4.13: Difference versus average Bland-Altman plot of UPC measures obtained from voided urine samples 
and cystocentesis with an active sediment. n=20 
Solid blue line represents the mean of the difference (bias) = -0.06 
Blue dashed lines represent the 95% limits of agreement from -0.32 to 0.21. 
  
Chapter 4 - Results 
84 
 
For samples with inactive sediments, the Passing-Bablok regression equation was y= -0.0160 + 
0.8000x with 95% CI for the intercept and slope of -0.0300 to 0.0469 and 0.6875 to 1.000 
respectively. A scatter plot with the regression line and 95% CI are shown in Figure 4.12. 
 
 
Figure 4.14: Passing-Bablok regression analysis of UPCs determined from voided urine samples and from 
cystocentesis samples with inactive sediments. n=23; UPC range 0.06-0.58; Spearman correlation coefficient 0.900, 
p<0.0005. Scatter chart with regression line and confidence bands for regression line shown. Regression line is 
solid.  































UPC from cystocentesis 
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Visual inspection of the Bland-Altman plot for urine samples with inactive sediments revealed 
good agreement between methods of collection for samples with a UPC <0.5. For samples with 
inactive sediments, the 95% limits of agreement calculated from the Bland-Altman plot span 
0.18. One data point fell outside the 95% limits of agreement. The cystocentesis UPC was 0.20 
and the voided sample was 0.06 in this case. A minimum of 40 samples with inactive sediments 
would however be needed to draw meaningful conclusions from this subset. 
 
Figure 4.15: Difference versus average Bland-Altman plot of UPC measures obtained from voided urine samples 
and cystocentesis samples with inactive sediments. n=23 
Solid blue line represents the mean of the difference (bias) = -0.04 
Blue dashed lines represent the 95% limits of agreement from -0.13 to 0.05. 
For all samples, Cohen’s kappa coefficient was κ=0.666, p<0.0005, corresponding to substantial 
agreement according to Landis and Koch (1977) between voided urine samples and 
cystocentesis samples for IRIS classification of proteinuria. This reduced to κ=0.489 for urine 
samples with active sediments and increased to κ=0.833 for urine samples with inactive 
sediments, corresponding to moderate and almost perfect agreement respectively (Landis and 
Koch, 1977).  
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4.4.3 Dipstick Parameters 
4.4.3.1 pH 
Out of 43 samples, a higher pH was observed in the voided sample in 18 (42%) cases. A higher 
pH was observed in the cystocentesis sample in 2 (5%) cases and no change in pH was 
observed in 23 (53%) cases. In seven cases, a pH difference of ≥ 1 unit was observed and in two 
cases a pH difference of 2 units was observed. In both cases where a difference of 2 units was 
observed, a higher pH was recorded in the voided sample.  
4.4.3.2 Glucose 
Forty and thirty-nine cystocentesis samples and voided samples respectively were negative for 
glucose. Tied observations for glucose measurement were recorded for 40 of 43 paired 
samples. In two of the discordant cases, glucosuria was documented in the voided sample only 
with ‘trace’ and ‘++’ results.  
4.4.3.3 Ketones 
Ketonuria was not detected in any sample. 
4.4.3.4 Bilirubin 
All 43 paired samples matched for bilirubin measurements. Forty-two paired samples were 
negative, and a ‘+’ result was recorded in one paired sample.  
4.4.3.5 Blood 
The median recorded score for blood was 0 for both voided samples and cystocentesis samples. 
Twenty-nine scores of 0 for both voided and cystocentesis samples were recorded. Fourteen 
samples scores ranged from 0.25-3 (‘Trace’ – ‘+++’) for each method of collection. Out of 43 
paired samples, an increased amount of blood was observed in the voided sample in 5 (12%) 
cases. An increased amount of blood was observed in the cystocentesis sample in 6 (14%) 
cases and no difference in the amount of blood present between the voided sample and 
cystocentesis sample was observed in 32 (74%) cases.  
4.4.4 Sediment Examination 
4.4.4.1 White Blood Cells 
The median score recorded for the presence of white blood cells in both voided samples and 
cystocentesis samples was 0 (range, 0-1). Out of 43 paired samples, an increased amount of 
white blood cells was observed in the voided sample in 3 (7%) cases. An increased amount of 
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white blood cells was observed in the cystocentesis sample in 13 (30%) cases and no difference 
in the amount of white blood cells present was observed in 27 (63%) cases. 
When evaluating the difference in the observation of pyuria recorded between voided and 
cystocentesis samples, matched observations were recorded in 42 of 43 paired cases. In 41 
cases, no pyuria was observed and in 1 case, pyuria was documented.  
In the discordant pair, pyuria was observed in the cystocentesis sample whilst only scant (Table 
3.6) white blood cells were observed in the voided sample. In this case, the voided sample 
remained in the litter tray for approximately 2 hours prior to collection and analysis. It is 
therefore possible some degeneration of any leukocytes present may have occurred.  
4.4.4.2 Red Blood Cells 
The median score recorded for the presence of red blood cells in voided samples and 
cystocentesis samples was 0 (range, 0-3) and 0 (range, 0-4) respectively. Out of 43 paired 
samples, an increased amount of red blood cells was observed in the voided sample in 7 (16%) 
cases. An increased amount of blood was observed in the cystocentesis sample in 10 (23%) 
cases and no difference in the amount of red blood cells present was observed in 26 (60%) 
cases.  
When evaluating the difference in the observation of haematuria recorded between voided 
and cystocentesis samples, matched observations were recorded in 39 of 43 paired cases. In 
30 cases, no haematuria was observed and in 9 cases, haematuria was documented.  
Of the 4 discordant pairs, haematuria was documented twice in only cystocentesis samples 
and twice in only voided samples. Paired scores for discordant results were 0.5 and 1 in two 
cases and 0 and 2 in two cases. In 3 cases the voided urine sample was obtained first. 
4.4.4.3 Squamous Epithelial Cells 
The median score recorded for the presence of squamous epithelial cells in voided samples 
and cystocentesis samples was 0.5 (range, 0-0.5) and 0 (range, 0-0.5) respectively. Out of 43 
samples, an increased number of squamous epithelial cells was observed in the voided sample 
in 20 (47%) cases. An increased number of squamous epithelial cells was observed in the 
cystocentesis sample in 3 (7%) cases and no difference in the number of squamous epithelial 
cells present was observed in 20 (47%) cases. All observations were deemed normal findings 
with no more than 5 squamous epithelial cells per HPF seen in any sample. 
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4.4.4.4 Transitional Epithelial Cells 
The median score recorded for the presence of transitional epithelial cells in voided samples 
and cystocentesis samples was 0 (range, 0-0.5) and 0 (range, 0-0.5) respectively. Out of 43 
samples, an increased number of transitional epithelial cells was observed in the voided 
sample in 3 (7%) cases. An increased number of transitional epithelial cells was observed in the 
cystocentesis sample in 6 (14%) cases and no difference in the amount of transitional epithelial 
cells present was observed in 34 (79%) cases. All observations were deemed normal findings 
with no more than 5 transitional epithelial cells per HPF seen in any sample. 
4.4.4.5 Bacteria 
The median score recorded for the presence of bacteria in voided samples and cystocentesis 
samples was 0 (range, 0-3) and 0 (range, 0-1) respectively. Out of 43 samples, an increased 
number of bacteria was observed in the voided sample in 5 (12%) cases. An increased number 
of bacteria  was observed in the cystocentesis sample in 4 (9%) cases and no difference in the 
number of bacteria  present was observed in 34 (79%) cases. 
When evaluating the difference in the observation of bacteriuria recorded between voided 
and cystocentesis samples, matched observations were recorded in 37 of 43 paired cases 
(90%). In 31 cases no bacteriuria was observed and in 6 cases bacteriuria was documented. In 
the discordant pairs, bacteriuria was observed in the voided sample only or cystocentesis 
sample only in 4 and 2 cases respectively.  
4.4.4.6 Casts 
Significant cylindruria was not observed in any sample. The scant presence of casts was 
documented in voided or cystocentesis samples in 10 and 14 cases respectively. For voided 
samples this was due to the presence of hyaline casts, coarse granular casts and fine granular 
casts in 3, 1 and 5 cases respectively. In 1 voided sample the scant presence of hyaline casts 
and fine granular casts were documented. For cystocentesis samples, hyaline casts, coarse 
granular casts and fine granular cast were documented in 6, 3 and 5 cases respectively.  
4.4.4.7 Crystals 
Scant crystalluria was documented in voided or cystocentesis samples in 12 and 20 cases 
respectively. Discordant results were obtained in 6, 1 and 18 cases for struvite, bilirubin and 
calcium phosphate crystalluria respectively.  
Of the 6 discordant struvite crystalluria cases, crystals were documented in the voided sample 
only in 4 cases.  
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In the case of bilirubin crystalluria, scant crystals were noted in the voided sample but not the 
cystocentesis sample. Both the voided and cystocentesis sample were positive for bilirubin on 
dipstick analysis. 
Of the 18 discordant cases of calcium phosphate crystalluria, crystals were documented in the 
cystocentesis samples only in 14 cases.  
4.4.5 Cytological Examination 
4.4.5.1 White Blood Cells 
The median score recorded for the presence of white blood cells in voided samples and 
cystocentesis samples was 0 (range, 0-0.5) and 0 (range, 0-0.5) respectively. For voided 
samples, no white blood cells were documented in 42 of 43 cases. A score of 0.5 was recorded 
in 1 case. For cystocentesis samples scores of 0 and 0.5 were recorded in 37 and 6 cases 
respectively. Pyuria based upon cytological examination as defined in Table 3.6 was not 
documented in any case.  
4.4.5.2 Red Blood Cells 
The median score recorded for the presence of white blood cells in voided samples and 
cystocentesis samples was 0 (range, 0-4) and 0 (range, 0-4). For voided samples, a score of >0.5 
was documented in 7 (16%) cases. For cystocentesis samples score of >0.5 was recorded in 9 
(21%) cases.  
Discordant results for the observation of haematuria based upon cytological examination was 
documented in 6 cases. In 4 of the 6 cases, haematuria was observed in the cystocentesis 
sample only. In 5 of the 6 cases, the voided sample was obtained first. 
For cystocentesis samples, of the 9 cases with cytological evidence of haematuria, 7 had 
evidence of haematuria on sediment examination. All 7 voided samples with cytological 
evidence of haematuria had evidence of haematuria on sediment examination.  
4.4.5.3 Squamous Epithelial Cells 
The median score recorded for the presence of squamous epithelia cells in voided samples and 
cystocentesis samples was 0.5 (range, 0-1) and 0 (range, 0-0.5) respectively. For voided 
samples, a score of 1 was documented in 5 (12%) cases. In 3 of the 5 cases, a score of 0.5 was 
recorded for the corresponding cystocentesis sample.  
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4.4.5.4 Transitional Epithelial Cells  
The median score recorded for the presence of transitional epithelia cells in voided samples 
and cystocentesis samples was 0 (range, 0-0.5) and 0 (range, 0-1) respectively. For voided 
samples a score of 0 was documented in all but one case.  For cystocentesis samples scores of 
0.5 and 1 were documented in 3 and 1 cases respectively.  
4.4.5.5 Bacteria 
Bacteria were observed in 11 and 2 voided samples and cystocentesis samples respectively. In 
the 2 cases bacteria were observed in the cystocentesis sample, bacteria were also observed in 
the voided sample.  
In the 11 voided samples, bacteria were specifically reported as being associated with 
squamous epithelial cells in 5 cases. Significant bacterial growth on urine culture was reported 
in only one case in which cytological evidence of bacteriuria was present.  
Of the 2 cystocentesis samples, scores of 0.5 and 3 were reported, no intra-cellular bacteria 
were reported in either case. No bacterial growth was reported on urine culture for either case. 
4.4.6 Urine Culture 
Bacterial growth was significantly more likely in voided samples compared to cystocentesis 
samples, p<0.0005, and was reported in 37 (86%) of 43 cases.  
When significant quantitative bacterial growth cut-off levels were applied, there was no 
significant difference in positive growth results between method of collection, p=0.5. 
Significant growth was only reported in 2 voided urine samples. In one case, a mixed growth of 
approximately 13000 cfu/mL was documented. The predominate organism was suspected to 
be coliform in nature. A profuse growth of a Proteus spp. was suspected in the other case due 
to the swarming nature of growth noted on the blood agar plate.  
No bacterial growth was observed in any cystocentesis sample.  
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Chapter 5  DISCUSSION 
5.1 THE DIAGNOSTIC APPROACH TO FELINE SUBCLINICAL BACTERIURIA AND URINARY 
TRACT INFECTIONS 
The main objectives of identifying urinalysis results predictive of subclinical bacteriuria and 
comparing methods of urine collection within this were not achieved due to the lack of 
subclinical bacteriuria cases recorded in this study. Instead, cases that may have been 
interpreted as subclinical bacteriuria or clinical UTI were described as a case series with 
differences between methods of urine collection highlighted. 
Genuine subclinical bacteriuria, as defined by Weese et al. (2019), was suspected in 2 cats (Cat 
A and Cat C in Section 4.1.2) in this study giving a prevalence of 4%. This falls within the wide 
prevalence range previously reported of 0.9%-28.8% and compares to the recently reported 
prevalence from a prospective study of 6.1% (Eggertsdottir et al., 2007, Litster et al., 2009, 
Moberg et al., 2019). 
A post-hoc sample size calculation with significance levels of alpha = 0.05 and beta = 0.2 
showed that 43 cats per study group would have been required to make statistically powerful 
conclusions regarding differences in urinalysis results between cats with subclinical bacteriuria 
and cats with UTI (Clincalc, 2019). The small number of urine culture-positive cats is a major 
limitation of this study but recruitment of such a sample size would not have been possible 
within the study period.   
All 4 cats with genuine subclinical bacteriuria or UTI in this study were female, which is 
consistently reported as a risk factor for their development (Lekcharoensuk et al., 2001, Litster 
et al., 2009).  
Out of 36 hyperthyroid cats screened, 1 case (2.7%) of subclinical bacteriuria was suspected. 
This is much lower than the reported prevalence from retrospective studies of positive urine 
cultures in hyperthyroid cats of 12%-17% (Mayer-Roenne et al., 2007, Bailiff et al., 2008). At 
the authors institution, cystocentesis and urine culture were part of the RAI suitability 
assessment. This was stopped approximately 5 months into the study and the number of 
hyperthyroid cats recruited reduced after this point. This likely contributed to the reduced 
prevalence of subclinical bacteriuria observed in this study.  
In this study, 53% of cats had CKD (of any IRIS stage) documented as a primary reason for 
presentation or a co-morbidity. Both cats with suspected subclinical bacteriuria had CKD of IRIS 
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stage 2 and 3 respectively. Only one previous retrospective study has identified CKD as a 
significant risk factor for subclinical bacteriuria (Puchot et al., 2017). In two larger scale 
retrospective studies, severity of azotaemia was not identified as a significant risk factor for 
positive urine culture, nor was CKD identified as a risk factor for subclinical bacteriuria in a 
recent prospective study of 179 cats (Bailiff et al., 2008, Mayer-Roenne et al., 2007, Moberg et 
al., 2019). 
Moberg et al. (2019) recently identified hepatic disease as a risk factor for subclinical 
bacteriuria, although this was not a finding in this study with both subclinical bacteriuria cats 
having  alanine aminotransferase (ALT) and alkaline phosphatase (ALP) enzyme activities 
within laboratory reference ranges. The study by Moberg et al. (2019) was underpowered but 
with an increased prevalence of asymptomatic bacteriuria reported in human patients with 
hepatic cirrhosis, further studies evaluating hepatic disease as a risk factor for subclinical 
bacteriuria in cats seem warranted.  
 A profuse growth of  an Enterococcus sp. was documented in the confirmed case of subclinical 
bacteriuria in this study (Cat A in Section 4.1.2.1). Enterococcus spp. are reported to account 
for up to 27% of positive feline urine cultures (Mayer-Roenne et al., 2007) and are significantly 
more likely to be isolated from cats with subclinical bacteriuria compared to other pathogens 
(Teichmann-Knorrn et al., 2018). In a review of Enterococcus spp. isolated from canine and 
feline urine samples, KuKanich and Lubbers (2015) reported that no clinical signs of lower 
urinary tract disease were recorded in over 54% of cats with E. faecalis-positive urine cultures. 
Interestingly Kopecny et al. (2019) suggested enterococcal infections in cats with SUB devices 
may be more associated with lower urinary tract clinical signs, although clinical signs of lower 
urinary tract disease were not reported in Cat A  in this study. The AST of the Enterococcus 
isolate in this study documented resistance to marbofloxacin and intermediate susceptibility to 
enrofloxacin and although the use of fluoroquinolones is not recommended for enterococcal 
UTI (Weese et al., 2019), the risk of transmission of antimicrobial resistant bacteria from 
animal to human is of concern (Dotto et al., 2018). 
Although the cystocentesis urine sample of Cat C (Section 4.1.2.2) was culture negative, due to 
repeated positive  follow up urine cultures, it is suspected the voided sample genuinely 
represented subclinical bacteriuria. It is unknown whether subclinical bacteriuria developed 
during the time between obtaining cystocentesis and voided samples (2160 hours) or whether 
this represents transient infection. Transient asymptomatic bacteriuria with E. coli has been 
described in human medicine (Biggel et al., 2019) and transient subclinical bacteriuria has been 
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described infrequently by White et al. (2016) although the causative pathogen was not 
reported in this study. 
It is likely the Enterococcus sp. or Streptococcus sp. suspected in the case of Cat E (Section 
4.1.3.2) represents contamination due to this sample being a voided sample. With the sample 
being posted to the laboratory it is possible the sample was not processed for up to 48 hours 
post-voiding and with lack of refrigeration throughout posting, caution should be exercised 
when interpreting this culture result. It is possible that a false negative result was obtained 
from SUB device sample in this case as false negative results from cystocentesis samples in 
dogs have also infrequently been reported (Sorensen et al., 2016). Financial considerations 
precluded the identification of bacterial species cultured from voided samples in this study.  
The AST of one E. coli isolate was performed at an external laboratory as requested by the 
referring veterinary surgeon for the case. The isolate was reported as susceptible to amoxicillin, 
clavulanate-potentiated amoxicillin, cephalexin, pradofloxacin, marbofloxacin, cefovecin and 
trimethoprim/sulphonamide and resistant to clindamycin. The methodology used to perform 
the AST was not provided by the external laboratory making comparisons between this isolate 
and the susceptibilities of two E. coli tested in-house difficult. Both isolates tested in-house 
were from cats with clinical UTIs. One isolate demonstrated resistance to ampicillin and 
cephalexin and susceptibility to the remainder of antimicrobials tested against. The second 
isolate demonstrated full susceptibility, which has been reported in up to 67.8% of E. coli 
isolated from canine and feline UTIs in the UK (Marques et al., 2016). 
Both cats classified as having UTIs (Cat D and Cat E, Section 4.1.3.2) had SUB devices fitted at 
the time a positive culture was documented. At the author’s institute, antimicrobials are not 
typically prescribed post-operatively to patients undergoing SUB device placement. In a 
retrospective study of 43 cats that had either ureteral stents or SUB devices placed, Kopecny et 
al. (2019) identified the post-operative use of antimicrobials significantly reduced the risk of 
subclinical bacteriuria or UTI post-discharge. Due to the retrospective nature of this study, 
antimicrobial prescribing was not standardised and so prospective studies aiming to identify 
appropriate protocols whilst avoiding overuse of antimicrobials are needed.  
Measurement of UPC appeared to be a good screening tool for positive urine cultures for 
cystocentesis samples. Using a cut-off of >0.4, sensitivity and specificity were calculated as 100% 
and 69% respectively.  For voided samples sensitivity and specificity were calculated as 66% 
and 80% but these values are likely influenced by the number of false positive urine cultures 
obtained using voided samples. These values should be interpreted with caution however 
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given Meindl et al. (2019) calculated sensitivity and specificity of proteinuria predicting a 
positive urine culture to be 43.5% and 37.2% respectively in a population of 394 dogs. The 
discrepancy in such values is likely due to the small sample size of this study.  
Bacteriuria defined by sediment examination was present in all but one case of positive urine 
cultures. In this study the sensitivity and specificity of sediment examination for bacteriuria 
were superior for cystocentesis samples (100% and 85% respectively) compared to voided 
samples (83% and 78% respectively). The sensitivity of cytological evaluation for bacteriuria 
was equivalent to sediment examination for both methods of collection. Specificity of 
cytological evaluation increased to 96% for cystocentesis samples but reduced slightly to 76% 
for voided samples. One voided sample documented a growth of Proteus spp., in which 
bacteriuria was not documented on sediment or cytological examination. Quantification of 
culture for Proteus spp. is difficult when only blood agar plates are used due to the swarming 
nature of their growth (Schaffer and Pearson, 2015). It is possible that low numbers of bacteria 
present precluded their identification on sediment or cytological examination in this case 
(Reppas and Foster, 2016b). 
From six positive urine cultures obtained from voided samples, three false positive results 
were suspected. Sensitivity and specificity were calculated to be 100% and 94% respectively 
and the positive predictive value was calculated to be 50%, suggesting positive cultures from 
voided samples should be interpreted with caution given the low prevalence of feline UTI and 
subclinical bacteriuria. This is in contrast to dogs where Sorensen et al. (2016) reported a 
sensitivity and specificity of 94% and 94% respectively and positive and negative predictive 
values of 88% and 97% respectively when using voided samples to determine significant 
bacteriuria. The study by Sorensen et al. (2016) included 94 dogs in which UTI was a 
differential diagnosis and so inclusion of the same number of cats in this study would be 
preferable in order to better compare the sensitivity and specificty of voided urine samples 
being used to diagnose UTI.  
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5.2 PROTEOMIC ANALYSIS 
This pilot investigation into the use of proteomics within feline subclinical bacteriuria and UTI 
aimed to identify potential biomarkers that could be more thoroughly investigated in future 
research. Protein searches against feline and bacterial databases were conducted to explore 
possible host or bacterial markers. Two unique proteins were identified in the 3 samples of 
subclinical bacteriuria analysed. Bacterial proteins were identified in most urine samples 
although the predominate genera present varied between the two runs of samples.  
When comparing voided samples to cystocentesis samples, up to 60% of proteins identified in 
each cat were present in both samples. Whilst moderate agreement between methods of 
collection was present, to ensure identification of true urinary biomarkers, future work should 
focus on samples obtained by cystocentesis mitigating the possible risk of sample 
contamination by commensal bacteria of the skin or distal urinary tract (Litster et al., 2011). 
Uromodulin was frequently identified as the most abundant protein in all study groups. 
Uromodulin is produced exclusively in the kidney, specifically by the tubular cells of the thick 
ascending limb of the loop of Henle, and is the most abundant protein identified in the urine of 
many mammalian species (Devuyst et al., 2017, Jepson et al., 2016). Although its full function 
has yet to characterised, uromodulin is thought to play a protective role in the prevention of 
UTI by binding pathogenic bacteria within the distal tubules and collecting ducts of the kidney 
(Vyletal et al., 2010). Garimella et al. (2017) demonstrated that increased concentrations of 
urinary uromodulin appeared to decrease the risk of UTI development in an elderly human 
population. Whether this finding is also true in cats is yet to be studied.  
Urinary fibronectin was identified in samples obtained from cats with and without lower 
urinary tract clinical signs. Fibronectin has previously been suggested as a marker for idiopathic 
cystitis in cats, with urinary concentrations found to be significantly higher in cats with 
idiopathic cystitis compared to cats with urolithiasis and bacterial cystitis (Lemberger et al., 
2011). Treutlein et al. (2013) later showed fibronectin concentrations did not decrease 
significantly over a 6 month follow up period in cats with idiopathic cystitis and were 
comparable to control cats beyond 14 days post-presentation. In this study, there were cases 
where the abundance of fibronectin relative to albumin were higher in cats without lower 
urinary tract clinical signs than cats with lower urinary tract clinical signs, although whether 
this difference was significant or not was not tested. Although urinary fibronectin 
concentrations may reflect underlying bladder pathology (Lemberger et al., 2011), its use as a 
biomarker to differentiate causes of lower urinary tract disease requires further study.  
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The identification of a neutrophil-expressed elastase in the urine of cats with suspected 
subclinical bacteriuria (Section 4.2.2.1.c) supports previous work showing that subclinical 
infections can incite an inflammatory response (Litster et al., 2009). Although in this study, this 
protein was identified in both cats with UTI and subclinical bacteriuria, the relative abundance 
was greater in cats with UTI and it is possible differential expression of inflammatory proteins 
may prove useful to differentiate cats with subclinical bacteriuria and UTI. In human medicine, 
urinary concentrations of interleukin-6 (IL-6) have been shown to discriminate between UTIs, 
asymptomatic bacteriuria and pyelonephritis in elderly patients (Kjolvmark et al., 2016). 
Interleukin-6 was not identified in any cat with a positive urine culture through proteomic 
analysis in this study although it’s lack of identification does not exclude its presence. Enzyme-
linked immunosorbent assays (ELISA) for IL-6 are available with detection limits of 1pg/mL for 
human urine (Kjolvmark et al., 2016), and it would prove interesting evaluate IL-6 
concentrations in urine samples from this study. Although an ELISA for the detection of feline 
serum IL-6 is commercially available, its ability to detect urinary IL-6 concentrations has yet to 
be validated (Habenicht et al., 2013). Given the day-to-day variation that exists in urinary 
protein excretion (Russo et al., 1986), repeated analysis of successive urine samples from the 
same cat would help to quantify variation in excretion of specific proteins, which would be 
required to validate any potential biomarker.  
The enzyme myeloperoxidase was identified in all cases of positive urine cultures. 
Myeloperoxidase was not identified in the deionised water control samples. Myeloperoxidase 
is a marker of inflammation and increased enzyme activity in urine has been identified in 
humans with UTI. Recent studies have suggested myeloperoxidase may serve as a useful non-
invasive test to diagnose UTI in human patients with a test sensitivity and specificity of 87% 
and 100% reported in one trial (Masajtis-Zagajewska and Nowicki, 2017). Myeloperoxidase was 
however also identified in many culture negative samples from cats with lower urinary tract 
clinical signs in this study (data not shown).  
There were two unique feline proteins that were identified in only cases of subclinical 
bacteriuria. These were of molecular weight 43.4kDa and 59.6kDa (Table 4.12). At present, the 
function of these proteins has yet to be elucidated. Further characterisation of the feline 
urinary proteome in larger cohorts of both healthy and diseased cats could potentially aid in 
identification of these proteins. Proteins of this molecular weight are freely filtered by healthy 
glomeruli (Brandt et al., 2014) although a post-renal origin cannot be excluded. Proteins of this 
molecular weight may also represent cleavage products of larger proteins due to the presence 
of endogenous proteases found in urine (Jepson et al., 2013). The BLAST search function of the 
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Uniprot database identified the uncharacterised protein with accession number A0A2I2V2Y7 
as having 61% of its sequence identical to human complement factor H, a regulator of the 
complement cascade (Makou et al., 2013, UniProt, 2019). 
For the second run of samples, two control samples of deionised water prepared in a similar 
manner to urine samples were analysed. The results of these analyses proved disappointing as 
the finding of both feline and bacterial proteins suggest that contamination had occurred at 
some point during preparation. Deionised water was aspirated from sterilised beakers with 
sterile needles and syringes. When control samples were first analysed, they were run on a gel 
with 3 urine samples. Following the unexpected acquisition of bacterial proteins in these 
samples, analysis was repeated. Control samples were run on a single gel with no other 
samples for the second analysis. The reduced number of proteins identified on the second 
analysis suggests contamination occurred during gel loading or during separation by 
electrophoresis. The Proteomics Facility mitigates the risk of sample contamination by running 
blank/control samples in between each test sample and this was confirmed during both runs 
of analysis. Given the same batch of reagents and buffers were used for the entire second run 
of analyses, the risk of contamination is a major limitation to this study and precludes valid 
conclusions being drawn from results of this run. Repeat analysis of all samples in the second 
run with fresh reagents would have helped confirm if this was the source of potential 
contamination. The keratin proteins identified in the second analysis of control samples are 
likely of human origin. 
In human medicine, the concept and understanding of a urinary microbiome has evolved 
rapidly over the last 10 years (Wolfe and Brubaker, 2019). Studies concerning the 
characterisation of the microbiome largely utilise genomic techniques, as is the case for the 
canine urinary microbiome (Burton et al., 2017). The canine urinary microbiome has been 
shown to contain bacteria largely belonging to the Proteobacteria phylum. This was consistent 
with our proteomic study where Pseudomonas spp. proteins were frequently identified 
(Section 4.2.3.1). These data suggest a urinary microbiome of a similar nature may exist in cats, 
although the bacterial genera identified in this study did not compare to those identified by 
Vester Boler et al. (2018). In that study, although bacteria belonging to the Proteobacteria 
phylum were the most abundant, Staphylococcus spp. were identified in each individual cat. 
That finding was not mirrored in this study where Staphylococcus spp. were rarely identified. 
Differences could be explained by the populations studied as Vester Boler et al. (2018) only 
evaluated healthy cats with no history of lower urinary tract disease, which was not the case 
for this study. Changes in the urinary microbiome have been reported in associations with 
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lower urinary tract clinical signs in humans (Komesu et al., 2018), and the same may be true in 
cats. Further proteomic and genomic studies of cats with and without lower urinary tract 
clinical signs seem warranted to gain an understanding of what constitutes a normal urinary 
microbiome and whether detectable changes occur with various disease states. Given the 
identification of bacterial proteins identified on analysis of deionised water, contamination 
must also be considered as an explanation for the differences observed, particularly for the 
second batch of analyses.  
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5.3 THE EFFECT OF NON-ABSORBENT HYDROPHOBIC SAND LITTER ON URINE PROTEIN-
TO-CREATININE MEASUREMENTS 
As this study was purely analytical in nature, no exclusions were applied regarding age, sex, 
neuter status, health status or urine sediment status.  
No data was available for analysis from the pilot investigation as all urine appeared to either 
be absorbed by the litter or evaporate over 24 hours. The initial amount of 20g of litter was 
based upon estimating the ratio of a typical voided urine volume of 42mL (Pelligand et al., 
2011) per 500g bag of litter used per tray. The reduced amount of 4g used in the later 
experiments was based upon the approximate surface area one 500g bag covered of a litter 
tray. As Petri dishes for this experiment were not covered, it is difficult determine whether 
absorption or evaporation contributed more to the loss of sample. As a 500g bag of litter does 
not often fully line a litter tray, it was theorised the non-absorbent litter may aid urine 
recovery by repelling urine from the litter surface to an unlined area of the tray.  
For the 40 samples analysed as part of experiment 2 and 3 ( Section 4.3.2), it is difficult to 
explain the increase in creatinine concentrations observed in the 24-hour samples. This finding 
disagrees with a study of 50 canine urine samples, in which urine creatinine concentrations 
were shown to remain stable at room temperature for up to 72 hours (Rossi et al., 2012). 
Protein concentrations would have been expected to increase in a similar fashion if sample 
dehydration was the sole explanation and covering of all Petri dishes with lids should also have 
mitigated this possibility. Sample dehydration alongside protein adsorption to litter cannot be 
fully excluded as in two control urine samples (covered in a Petri dish without any litter), 
although not significant, increases in both urinary protein and creatinine concentrations were 
observed at 24 hours. Absolute mean % changes for urinary protein and creatinine 
concentrations were with the allowable total error for analytical variability of serum analytes 
of <10% and <20% respectively as defined by the American Society of Veterinary Clinical 
Pathology Quality Assurance and Laboratory Standards Committee (Harr et al., 2013).  
Confidence intervals for the Passing-Bablok regression equation intercept and slope were 
subjectively narrow and included 0 and 1 respectively. This suggests minimal constant and 
proportional error when using urine exposed to non-absorbent hydrophobic sand for 24 hours 
for UPC measurements compared to cystocentesis samples.  
Inspection of the Bland-Altman plot (Figure 4.9) revealed agreement between UPC at baseline 
and 24 hours. The two measurements that fell outside the 95% limits of agreement according 
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to the Bland-Altman plot had mean UPCs of a much larger magnitude than the rest of the data 
set and are considered outliers. Absolute % changes for these values of 14.7% and 6.6% were 
below the observed total error for UPC values in their range of 18.87% and so differences 
observed between these paired samples may purely reflect analytical variability.  
Agreement for IRIS classification of proteinuria was almost perfect as measured by Cohen’s 
kappa according to Landis and Koch (1977). The two samples that changed classification had 
baseline UPCs of 0.26 and 0.46 and 24-hour UPCs of 0.18 and 0.39 respectively. Changes in IRIS 
proteinuria category would therefore not have occurred if values were reported to one 
decimal place. These changes corresponded to absolute % changes of 31.38% and 15.22% 
respectively. Guidelines for total allowable error for UPC measurement do not exist in 
veterinary medicine or human medicine (CLIA, 1992, Harr et al., 2013). Because of this, the 
calculated observed total error of the Diagnostic Laboratory analyser for UPC measurements 
was used to compare against % changes observed in paired samples. Observed total error was 
calculated by combining low and high range quality control materials for urinary protein and 
urinary creatinine supplied by the analyser manufacturer. Low control targets for protein and 
creatinine were 8mg/dL and 78.05mg/dL respectively, giving a low-range target UPC of 0.10. 
High control targets for protein and creatinine were 70mg/dL and 177.60mg/dL respectively, 
giving a high-range target UPC of 0.39. The inter-assay observed total error for low- and high-
range UPCs were calculated to be 29.39% and 18.87% respectively. Analytical variability alone 
may therefore be responsible for the misclassification of the latter sample and 31.38% is 
considered acceptably close to 29.39%. Although the precision of UPC measurements at the 
authors institute appears superior to comparable studies, the magnitude of the inter-assay CV 
(11.48%) supports the recommendations of Giraldi et al. (2018) that repeated UPC measures 
should be obtained when ratios are close to the clinical threshold values of 0.2 and 0.4. 
The agreement measures of Bland-Altman analysis and Cohen’s kappa for IRIS proteinuria 
classification both suggest that the use of non-absorbent sand litter has minimal effect on UPC 
measurement in feline urine and that samples exposed to this litter substrate are acceptable 
for analysis.  
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5.4 THE EFFECT OF URINE SAMPLE COLLECTION TECHNIQUE ON COMMON URINALYSIS 
PARAMETERS 
In this study, identical urinalyses were performed on voided urine samples and cystocentesis 
samples obtained from the same cat within a 24-hour period. Few studies exist evaluating the 
effect of method of collection on various urinalysis parameters.  
Regarding USG, although overall no significant difference in USG was observed between 
methods of collection, as 1.035 is generally accepted as adequate urine concentrating ability in 
the cat, changes crossing this threshold were also evaluated (Sparkes et al., 2016). However, in 
this study, observations regarding water intake and the use of IVFT were not standardised and 
these will have impacted some of the changes seen more so than the method of urine 
collection making conclusions regarding the effect of sample collection technique on USG 
difficult. 
No significant difference in urinary pH was observed between voided samples and 
cystocentesis samples when using the benchtop pH meter. Differences in pH of larger 
magnitudes were observed when using the urine dipstick. Correlations between the benchtop 
meter and dipstick were not calculated for this study but previous studies have demonstrated 
greater inaccuracy and imprecision for urine dipsticks (Raskin et al., 2002). Timing of urine 
sampling in relation to eating was not monitored in this study. Increases in urinary pH can be 
seen following eating, the so-called ‘post-prandial alkaline tide’ (Reppas and Foster, 2016a). 
Food was withheld from all cats prior to cystocentesis as cats were sedated or anaesthetised 
for this procedure. Increased urinary pH may have been observed in voided samples if food 
was not restricted around the time of sample collection. 
To the best of the authors’ knowledge only two studies exist comparing UPCs of urine obtained 
by cystocentesis and free catch methods in cats. In experimental conditions, Monroe et al. 
(1989) showed no significant difference between UPCs for urine samples obtained by 
cystocentesis and for voided samples collected from a modified plastic oil pan in 12 cats. 
Although not significant, a trend of increased UPCs in voided samples was observed. In a 
second study, Vilhena et al. (2015) demonstrated linear correlation between UPCs from 
cystocentesis samples and urine obtained by manual bladder expression in 43 cats.  
In the present study, although agreement between methods of collection for all samples 
appeared acceptable, agreement varied considerably according to sediment status. Three data 
points fell outside the 95% limits of agreement in the Bland-Altman plot for all samples. In two 
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cases, the IRIS category for proteinuria did not change. In the third, the voided sample was 
classified as borderline proteinuric and the cystocentesis classified as proteinuric. However, if 
UPCs were reported on only one decimal place, then no change in IRIS category for proteinuria 
would have occurred. 
Superior agreement between methods of collection was found for samples with inactive 
sediments compared to active sediments. For urine samples with an active sediment, the 
width of the 95% limits of agreement calculated by Bland-Altman analysis (-0.3359 to 0.2087) 
was large and greater than that of inactive sediments (-0.1284 to 0.05099). Agreement 
between methods of collection for IRIS classification of proteinuria was also superior for urine 
samples with an inactive sediment compared to samples with an active sediment. Although 
the Cohen’s kappa coefficient for all samples represented substantial agreement, a coefficient 
of 0.666 indicates that up to 65% of the data may be erroneously categorised (McHugh, 2012). 
Cohen’s kappa coefficient for inactive sediments was 0.833 corresponding to almost perfect 
agreement, whilst for active sediments the coefficient was 0.489 corresponding to only 
moderate agreement (Landis and Koch, 1977). The author believes this to be the first study 
where voided samples collected using a non-absorbent litter have been compared to 
cystocentesis samples and this further supports earlier work by demonstrating both 
correlation and agreement between UPCs determined from voided samples and cystocentesis 
samples with inactive sediments and UPC <0.5 (Monroe et al., 1989, Vilhena et al., 2015).  
For the dipstick parameters of glucose, ketones, bilirubin and blood. Almost all results 
obtained were negative irrespective of method of collection. Two cases of glucosuria were 
documented in voided samples only. Boag et al. (2019) demonstrated that improper use of the 
dipstick by dripping sample onto reagent pads instead of submerging the dipstick is more likely 
to produce a positive reaction for glucose. In this study however, all urinalyses were 
performed according to dipstick manufacturer guidelines by submerging reagent pads in the 
sample. Transient glucosuria of low magnitude can occur in cats due to stress (Piech and 
Wycislo, 2018) and this may explain the discordant results observed regarding glucosuria. This 
study demonstrated good agreement between methods of urine collection for negative results 
of the aforementioned dipstick parameters but more data spanning a wider range of results 
would be needed to comment on agreement for positive results.   
Very few cases of pyuria were documented in this study with only one paired sample 
producing discordant results for sediment examination. No cases of pyuria were documented 
using cytology suggesting good agreement between sediment examination and cytological 
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findings for the absence of pyuria. Similarly, haematuria was documented in ~20% samples for 
each method of collection on sediment examination. For sediment examination, agreement in 
findings for haematuria was documented in 90% cases. Three-quarters of these cases were 
non-haematuric and so more data would be needed to confirm agreement between methods 
of collection for haematuric urine samples. Cytological evidence of haematuria was also 
present in ~20% of cases. In only two cases was cytological evidence of haematuria present 
that was not evidence on sediment examination. These data suggest good agreement between 
both methods of collection and sediment and cytological examination for the absence of 
pyuria and haematuria.  
Bacteria were observed more frequently in voided samples compared to cystocentesis samples. 
In human medicine, low numbers of bacteria are frequently observed on microscopic 
examination of voided urine samples (Ringsrud, 2001). In 8 cases, bacteriuria was documented 
on sediment examination in which corresponding urine cultures were negative. This highlights 
the imperfect nature of sediment exam being able to predict culture status previously 
reported (O'Neil et al., 2013). The use of cytological examination has been shown to improve 
the sensitivity and specificity of being able to predict culture status (Swenson et al., 2011), 
although due to the low number of positive urine cultures, this was not evident in this study.  
Only low numbers of bacteria were observed in voided specimens with a maximum score for 
any sample of 0.5 for cytological examination. In 45% of cases these bacteria were associated 
with squamous epithelial cells suggestive of contamination rather than true infection. No intra-
cellular bacteria were noted in the two cystocentesis samples in which bacteria were observed 
(Section 4.4.4.5). More samples positive for bacteria, particularly with intra-cellular bacteria 
documented, are required to comment on agreement between voided urine samples and 
cystocentesis samples for identification of bacteria on cytological examination.  
Regarding urine culture, in this study 86% of voided samples resulted in bacterial growth. 
However only 2 of these resulted in significant bacterial growth of >104 cfu/mL as per Weese 
et al. (2011). No bacterial growth was documented in any sample obtained by cystocentesis 
suggesting the two positive cultures from voided samples represent contamination. Magnitude 
of bacterial growth is often low with contamination, but Lees et al. (1984) demonstrated that 
contaminant growths of >104 cfu/mL do occur infrequently. In a study comparing methods of 
urine collection in 79 cats, van Duijkeren et al. (2004) showed that voided samples often 
produced mixed cultures making interpretation difficult. This was evident in this study with 
one growth obviously mixed in nature as stated in Section 4.4.6. It was unclear whether the 
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culture containing the Proteus sp. was pure as its swarming nature on blood agar can 
outcompete other bacterial species that may be present (Schaffer and Pearson, 2015). 
Contaminant bacterial species cultured from voided specimens can often be uropathogens in 
their own right (Lees et al., 1984, Sorensen et al., 2016), as was the case in this study. These 
results suggest that cystocentesis should continue to be the preferred sampling technique 
when bacterial culture is required in cats.   
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Chapter 6  FUTURE WORKS 
Limitations to each study reported in this thesis have been addressed in Chapter 5 . Yet despite 
these limitations, several areas for future research have also been highlighted as a result of 
this work.  
The number of cases of suspected subclinical bacteriuria and UTI in this study precluded 
meaningful statistical analyses of urinalysis results. Due to the apparent low prevalence of 
subclinical bacteriuria, the recruitment of a powerful enough sample size within a reasonable 
study period does not seem feasible in many situations. This difficulty was also encountered by 
Moberg et al. (2019) in a prospective study of 179 cats in which only 11 cats with subclinical 
bacteriuria were identified. To overcome this, collaborative studies between multiple centres 
have the potential to achieve larger recruitment targets. Depending on study aims, institutes 
contributing to multi-centre studies concerning bacterial infections such as subclinical 
bacteriuria should ideally be in the same geographical area given the temporal variation in 
uropathogen prevalence and antimicrobial resistance patterns (Marques et al., 2018). 
Alternatively, risk factor analysis for subclinical bacteriuria, particularly in the United Kingdom, 
could occur through the use of veterinary practice records surveillance programmes such as 
the Veterinary Companion Animal Surveillance System (VetCompass™) or the Small Animal 
Veterinary Surveillance Network (SAVSNET). 
Subclinical bacteriuria and UTI occur frequently in cats with urological implants (Kopecny et al., 
2019). At the authors institute, post-operative antimicrobial therapy is not standard procedure 
following the placement of any urological implant, yet anecdotally the rate of post-operative 
subclinical bacteriuria or UTI does not appear higher than institutes where post-operative 
antimicrobials are prescribed. There is therefore an urgent need for a prospective study 
evaluating the effect of peri- and post-operative antimicrobial therapy for urological implant 
surgeries. A comparison of prescribing protocols could help to refine antimicrobial prescribing 
patterns and reduce any unnecessary antimicrobial use.  
The risk of sample contamination during proteomic analysis in Section 4.2 is a major limitation 
of the study and as stated, prevents valid conclusions being drawn from the results. The results 
of the feline and bacterial protein database searches do however suggest that a complex 
urinary proteome and urinary microbiome are present in cats, as has been shown in other 
species (Brandt et al., 2014, Brubaker and Wolfe, 2016, Burton et al., 2017). Better 
characterisation of the feline urinary proteome in both health and diseased states has the 
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potential to identify a whole host of biomarkers that could be exploited to develop diagnostic 
tests for subclinical bacteriuria, UTI and other diseases.  
The enzyme myeloperoxidase was identified frequently in cats with subclinical bacteriuria and 
UTI in this study. The enzyme was also identified in cats presenting with lower urinary tract 
clinical signs that had negative urine cultures. Through proteomic techniques alone, urinary 
myeloperoxidase activity in samples analysed could not be established. In human medicine, 
increased urinary myeloperoxidase activity has been shown to be able to discriminate between 
sterile and infected urine samples (Ciragil et al., 2014). Although myeloperoxidase activity has 
been shown to be a non-specific inflammatory maker in humans (Masajtis-Zagajewska and 
Nowicki, 2017) establishment of activity levels in feline urine may prove useful in 
differentiating the various causes of lower urinary tract disease.  
An increased understanding of the human urinary microbiome has furthered understanding of 
a number of  urinary tract disease pathogeneses (Wolfe et al., 2012). A definitive aetiology for 
the leading cause of feline lower urinary tract disease, idiopathic cystitis, has yet to be 
identified (Buffington, 2011). With feline lower urinary tract disease accounting for up to 5% of 
primary care veterinary practices feline caseload (Sparkes, 2018), there is a clear need for 
further research in this area. Combining proteomic and genomic techniques could give an 
increased understanding of what constitutes a healthy feline urinary microbiome; 
understanding how this microbiome changes in disease states would almost certainly increase 
the understanding of feline lower urinary tract disease.  
Finally, this study was able to show that the use of non-absorbent hydrophobic sand litter had 
minimal effect on UPC measurements (Section 4.3). When this was taken further to compare 
the UPC between voided urine samples and cystocentesis samples (Section 4.4.2.3), improved 
agreement between methods of collection was seen for samples with inactive sediments 
compared to active. When analyses of active and inactive sediments were performed 
separately, the sample sizes were 20 and 23 respectively. A minimum of 40 samples are 
recommended for method comparison studies (Jensen and Kjelgaard-Hansen, 2006), and so a 
further 20 samples with active sediments and 17 samples with inactive sediments should be 
analysed to confirm the agreement reported in this study.  
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